{"gene":"EIF2AK2","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1999,"finding":"PKR (EIF2AK2) is autophosphorylated and activated upon binding to dsRNA, leading to phosphorylation of eIF2α and inhibition of protein synthesis; PKR also induces transcription of inflammatory genes via activation of NF-κB and other transcription factors.","method":"Biochemical assays, in vitro kinase assays, cell-based studies","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1–2 — foundational mechanism replicated across many labs, multiple orthogonal methods","pmids":["10557102"],"is_preprint":false},{"year":2005,"finding":"PKR activation requires catalytic-domain dimerization, which triggers Thr446 autophosphorylation within the activation segment; helix αG is critical for specific recognition of eIF2α substrate; mutations on the dimerization surface block autophosphorylation and eIF2α phosphorylation.","method":"Mutagenesis, in vitro kinase assays, yeast growth suppression, pseudosubstrate binding","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with mutagenesis and functional validation in a single rigorous study","pmids":["16179259"],"is_preprint":false},{"year":2006,"finding":"PKR activation by dsRNA or PACT is mediated by relief of an intramolecular autoinhibitory interaction between the kinase domain PACT-binding motif (PBM) and the dsRNA-binding domain; disruption of this interaction by mutations or a decoy PBM peptide constitutively activates PKR.","method":"NMR, biochemical assays, point mutagenesis, in vitro kinase assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — NMR structural analysis combined with mutagenesis and functional biochemical validation","pmids":["16785445"],"is_preprint":false},{"year":2006,"finding":"dsRNA functions primarily to induce dimerization of PKR via the kinase domain rather than solely releasing autoinhibition; a minimum of 30 bp dsRNA is required to bind two PKR monomers and elicit autophosphorylation.","method":"Biophysical analyses, sedimentation velocity, in vitro autophosphorylation assays with dsRNAs of varying length","journal":"Trends in biochemical sciences","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with biophysical methods, supported by independent structural data","pmids":["17196820","18599071"],"is_preprint":false},{"year":2008,"finding":"PKR requires dsRNA of at least 30 bp to bind two monomers and undergo dimerization-driven autophosphorylation; sequential, non-cooperative attachment of PKR monomers to dsRNA leads to dimerization via the kinase domain.","method":"Sedimentation velocity analytical ultracentrifugation, in vitro autophosphorylation assays","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — quantitative biophysical reconstitution with defined substrates","pmids":["18599071"],"is_preprint":false},{"year":2007,"finding":"A conserved intermolecular salt bridge between Arg262 and Asp266 at the PKR kinase domain dimer interface is essential for PKR activity; charge-swap double mutations restore function, confirming this interface is critical for the eIF2α kinase family.","method":"Mutagenesis, yeast functional assay, in vitro kinase assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis with in vitro and in vivo validation, charge-swap rescue experiment","pmids":["17202131"],"is_preprint":false},{"year":2013,"finding":"PKR activation requires dimerization-induced cis-phosphorylation of Thr446 in the activation loop; dimerization precedes and stimulates activation loop autophosphorylation, and these processes are mutually exclusive yet interdependent.","method":"Yeast functional system, engineered bypass mutants, in vitro kinase assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — genetic epistasis with in vitro biochemical validation in reconstituted system","pmids":["24338483"],"is_preprint":false},{"year":2000,"finding":"PKR activates NF-κB independent of its kinase activity by physically interacting with the IKKβ subunit of the IKK complex, as demonstrated by GST pull-down and catalytically inactive mutant PKR still activating NF-κB.","method":"GST pull-down, co-expression of kinase-dead PKR mutants, NF-κB reporter assay, PKR-null cell reconstitution","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal pulldown with kinase-dead mutant dissecting kinase-dependent vs. -independent functions","pmids":["10848580"],"is_preprint":false},{"year":2004,"finding":"PKR physically interacts with TRAF2 and TRAF5 via a TRAF-interaction motif in its kinase domain; this interaction is induced by PKR dimerization and is required for PKR-mediated NF-κB activation.","method":"Co-immunoprecipitation, confocal colocalization, TRAF-deficient cell lines, dominant-negative expression, computer docking","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP with TRAF-null epistasis and mutational analysis","pmids":["15121867"],"is_preprint":false},{"year":2012,"finding":"The SH2 domain of cytoplasmic STAT3 interacts with the catalytic domain of EIF2AK2/PKR to inhibit its activating autophosphorylation; disruption of this interaction (by STAT3 inhibitors or palmitate) leads to PKR-dependent eIF2α phosphorylation and autophagy induction.","method":"Recombinant protein pull-down, co-immunoprecipitation, pharmacological/genetic STAT3 inhibition, PKR knockdown, STAT3 domain mutants","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1–2 — recombinant protein interaction confirmed by multiple orthogonal methods including domain mutagenesis","pmids":["23084476","23221979"],"is_preprint":false},{"year":2012,"finding":"PKR is required for inflammasome activation in macrophages; PKR autophosphorylation precedes inflammasome assembly, and PKR physically interacts with NLRP3, NLRP1, NLRC4, AIM2, and ASC. Reconstitution of inflammasome activity in a cell-free system with recombinant NLRP3, ASC, and pro-caspase-1 required PKR autophosphorylation.","method":"Co-immunoprecipitation, PKR genetic knockout, pharmacological inhibition, cell-free reconstitution assay","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 — cell-free reconstitution plus genetic KO with multiple orthogonal methods in high-impact journal","pmids":["22801494"],"is_preprint":false},{"year":2013,"finding":"IFN-induced PKR interacts with RIP1 to initiate necrosome formation and trigger RIP1/RIP3-mediated necrosis when FADD is absent or caspases are inactivated; PKR kinase activity (not RIP1 kinase activity) is required for this process.","method":"Co-immunoprecipitation, PKR-deficient cells, kinase-dead mutants, genetic knockouts, live-cell imaging","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP with genetic epistasis across multiple knockout cell lines","pmids":["23898178"],"is_preprint":false},{"year":2019,"finding":"Endogenous circRNAs form 16–26 bp imperfect RNA duplexes and act as inhibitors of PKR; upon viral infection, RNase L degrades circRNAs, which is required for PKR activation in innate immune responses. Overexpression of dsRNA-containing circRNA alleviates aberrant PKR activation in SLE patient cells.","method":"Cellular overexpression/knockdown, RNase L-mediated degradation assays, PKR phosphorylation analysis, patient PBMCs","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (genetic, pharmacological, patient-derived) in high-impact journal","pmids":["31031002"],"is_preprint":false},{"year":2010,"finding":"PKR is activated by uridine-containing in vitro transcribed mRNA but not by pseudouridine-containing mRNA; PKR binds uridine-containing mRNA more efficiently, and pseudouridine substitution reduces PKR activation and diminishes eIF2α-mediated translation inhibition.","method":"RNA pull-down, in vitro kinase assay, PKR knockout cell validation","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — biochemical binding assay combined with PKR-null cell rescue experiment","pmids":["20457754"],"is_preprint":false},{"year":2014,"finding":"PKR is activated during mitosis in uninfected cells by binding to dsRNAs formed by inverted Alu repeats (IRAlus) that become accessible when nuclear structure breaks down; activated pPKR suppresses global translation via eIF2α phosphorylation and regulates JNK, cyclin A/B, PLK1 levels, and histone H3 phosphorylation; PKR disruption causes cytokinesis defects.","method":"RNAi knockdown, dominant-negative mutant expression, immunoprecipitation of dsRNA, live-cell imaging, flow cytometry","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods demonstrating both molecular mechanism and cellular phenotype","pmids":["24939934"],"is_preprint":false},{"year":2018,"finding":"PKR interacts with endogenous mitochondrial RNAs (mtRNAs) that form intermolecular dsRNAs due to bidirectional transcription; these mtRNAs regulate PKR and eIF2α phosphorylation; PKR activation by mtRNAs is counteracted by PKR phosphatases, and disruption of phosphatases causes apoptosis.","method":"Formaldehyde crosslinking and immunoprecipitation sequencing (fCLIP-seq), RNAi knockdown, PKR phosphorylation assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — genome-wide crosslinking approach combined with functional validation","pmids":["30174290"],"is_preprint":false},{"year":2001,"finding":"The Hsp90 chaperone complex (Hsp90 and co-chaperone p23) binds to PKR through both its N-terminal dsRNA-binding region and kinase domain; dsRNA or Hsp90 inhibitors (geldanamycin, radicicol) rapidly dissociate Hsp90/p23 from PKR and activate it, triggering eIF2α phosphorylation.","method":"Co-immunoprecipitation, geldanamycin treatment, in vivo and in vitro PKR activation assays, yeast Hsp90 mutant system","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP with domain mapping and pharmacological dissection in both yeast and mammalian cells","pmids":["11447118"],"is_preprint":false},{"year":2009,"finding":"Stress-induced phosphorylation of specific serine residues in domain 3 of PACT increases its affinity for PKR, leading to PKR autophosphorylation and eIF2α phosphorylation; phosphomimetic aspartate substitutions at these serines enhance PACT-PKR binding and PKR activation in vitro.","method":"In vitro binding assays, in vitro kinase assays, phosphomimetic mutagenesis","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with quantitative binding measurements and phosphomimetic mutants","pmids":["19580324"],"is_preprint":false},{"year":2008,"finding":"PACT-mediated PKR activation via direct protein-protein interaction is essential for ER stress-induced apoptosis; PACT is phosphorylated in response to tunicamycin and activates PKR; PACT-null and PKR-null cells are resistant to ER stress-induced apoptosis with defective eIF2α phosphorylation.","method":"PACT/PKR null cell lines, reconstitution with cDNA, in vitro interaction assays, apoptosis assays","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 2 — null cell reconstitution with multiple orthogonal readouts","pmids":["19007793"],"is_preprint":false},{"year":2011,"finding":"Heparin activates PKR by binding to the kinase domain (not the dsRNA-binding domain) and allosterically enhancing PKR dimerization, leading to autophosphorylation; heparin hexasaccharides are sufficient for activation.","method":"Analytical ultracentrifugation, in vitro autophosphorylation assays, thermodynamic linkage analysis","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 — biophysical reconstitution with distinct mechanism from dsRNA activation","pmids":["21978664"],"is_preprint":false},{"year":2015,"finding":"Small nucleolar RNAs (snoRNAs) interact with PKR after metabolic stress (palmitic acid treatment) via its dsRNA-binding domain; a subset of snoRNAs can bind and activate PKR in vitro, and snoRNA transfection activates PKR in cells.","method":"RIP-Seq, UV crosslinking immunoprecipitation with RT-qPCR, in vitro PKR activation assay, snoRNA transfection","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — in vitro reconstitution confirmed by cell-based approaches with dsRBD mutant controls","pmids":["25848059"],"is_preprint":false},{"year":2014,"finding":"DHX36 forms a complex with PKR in a dsRNA-dependent manner and facilitates dsRNA binding and phosphorylation of PKR through its ATPase/helicase activity, thereby promoting antiviral stress granule formation and RIG-I signaling.","method":"Co-immunoprecipitation, DHX36 knockout inducible MEF cells, PKR phosphorylation assays","journal":"PLoS pathogens","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP with genetic KO showing physiological relevance","pmids":["24651521"],"is_preprint":false},{"year":2018,"finding":"Loss of PRKRA (PACT) by mis-splicing in TIA1/TIAL1 double-knockout cells triggers EIF2AK2/PKR activation and stress granule formation; ectopic PRKRA cDNA or EIF2AK2 knockout rescues this phenotype, placing PRKRA upstream of EIF2AK2 in RNA stress sensing.","method":"PAR-CLIP, double gene knockout, genetic rescue with cDNA or knockout","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — epistasis confirmed by genetic rescue in both directions","pmids":["29429924"],"is_preprint":false},{"year":2008,"finding":"Positively selected residues in the PKR kinase domain near the eIF2α binding site confer species-specific differences in sensitivity to poxviral pseudosubstrate inhibitors; substitution of these residues alters inhibitor sensitivity while maintaining eIF2α phosphorylation activity.","method":"Evolutionary analysis, site-directed mutagenesis, in vitro kinase assays with poxviral inhibitors","journal":"Nature structural & molecular biology","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis-based functional mapping of eIF2α binding site with in vitro validation","pmids":["19043413"],"is_preprint":false},{"year":2022,"finding":"PKR forms dynamic cytosolic condensates (dsRNA-induced foci, dRIFs) in response to elevated dsRNA; dRIFs contain dsRNA and enriched dsRNA-binding proteins (ADAR1, Stau1, NLRP1, PACT); dRIF formation correlates with and precedes PKR activation and translation repression, and dRIF disruption enhances eIF2α phosphorylation.","method":"Live-cell imaging, immunofluorescence, eIF2α phosphorylation assays, dsRNA stimulation","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — direct live-cell localization linked to functional PKR activation with mechanistic follow-up","pmids":["35939694"],"is_preprint":false},{"year":2022,"finding":"PKR signaling involves assembly of dynamic PKR clusters driven by ligand binding to the sensor domain and front-to-front interfaces between kinase domains; eIF2α is excluded from PKR clusters, and cluster disruption enhances eIF2α phosphorylation, suggesting clustering buffers downstream ISR signaling.","method":"Live-cell imaging, mutagenesis, eIF2α phosphorylation assays, proximity-based approaches","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — novel structural model with functional validation, single lab","pmids":["35522180"],"is_preprint":false},{"year":2023,"finding":"ADAR1p150 cytoplasmic isoform prevents PKR activation via its dsRNA-binding activity (editing-independent mechanism), while ADAR1 RNA editing prevents MDA5 activation; deleting both MDA5 and PKR fully rescues embryonic lethality of Adar1p150-/- mice.","method":"Triple knockout mouse genetics, epistasis analysis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — in vivo epistasis with full phenotypic rescue in mouse model","pmids":["37797622"],"is_preprint":false},{"year":2024,"finding":"ADAR1 dsRBD3 directly interacts with the PKR kinase domain on dsRNA to inhibit PKR activation; AlphaFold modeling and mutagenesis of the ADAR1 dsRBD3–PKR contact surface abolish co-immunoprecipitation, PKR inhibition, and co-localization; editing-inactive ADAR1 retains PKR-inhibitory activity but dsRNA binding is required.","method":"Co-immunoprecipitation, AlphaFold structural modeling, mutagenesis, in vivo/in vitro PKR phosphorylation assays","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — structural model with mutagenesis validation, reciprocal Co-IP, and functional assays","pmids":["39146181"],"is_preprint":false},{"year":2019,"finding":"PKR promotes cGAS condensation and DNA sensing by an RNA-dependent association with G3BP1 to facilitate G3BP1 foci formation; loss of G3BP1 blocks cGAS condensation and suppresses interferon response to cytoplasmic DNA.","method":"Co-immunoprecipitation, knockdown, immunofluorescence, interferon response assays","journal":"Science signaling","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP with functional knockdown, single lab","pmids":["31772125"],"is_preprint":false},{"year":2020,"finding":"Structured expansion RNAs (CAG, CCUG, CAGG, G4C2) activate PKR, which promotes RAN (repeat-associated non-AUG) translation; blocking PKR with dominant-negative PKR-K296R or PKR-KO reduces RAN protein levels; metformin inhibits PKR and reduces RAN proteins and improves pathology in C9orf72 ALS/FTD mice.","method":"PKR-KO cells, dominant-negative PKR, AAV-mediated PKR inhibition in transgenic mice, RAN protein quantification","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function with in vivo mouse model and multiple orthogonal approaches","pmids":["32690681"],"is_preprint":false},{"year":2012,"finding":"PKR activation in colonic epithelial cells promotes eIF2α-mediated UPR signaling, STAT3, and AKT activation to protect against DSS-induced colitis; PKR-/- mice show impaired UPR, reduced STAT3/AKT phosphorylation, and more severe colitis.","method":"PKR knockout mice, bone marrow reconstitution, western blot, histology","journal":"Inflammatory bowel diseases","confidence":"Medium","confidence_rationale":"Tier 2 — clean knockout with defined molecular phenotypes, single lab","pmids":["22275310"],"is_preprint":false},{"year":2016,"finding":"PKR kinase activity represses cryopyrin (NLRP3) inflammasome activity by inhibiting protein translation of inflammasome constituents to prevent initial priming; kinase-dead knock-in and PKR-null mice showed enhanced inflammasome activity, contradicting earlier findings that PKR promotes inflammasome activation.","method":"Knock-in mouse with kinase-dead PKR point mutation, PKR-null mouse, inflammasome activity assays","journal":"Cell research","confidence":"High","confidence_rationale":"Tier 2 — dual transgenic mouse genetics (kinase-dead knock-in vs. full KO) dissecting kinase-dependent function","pmids":["26794869"],"is_preprint":false},{"year":2018,"finding":"Stress-induced phosphorylation of TRBP enhances its interaction with PKR and inhibits PKR activity more efficiently, promoting cell survival by preventing sustained PKR-mediated apoptosis.","method":"Co-immunoprecipitation, TRBP phospho-mutants, PKR activity assays, cell survival assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP with functional follow-up, single lab","pmids":["29348664"],"is_preprint":false},{"year":2012,"finding":"PKR activation during ER stress (via PACT) promotes p53 sumoylation on Lys386 through interaction with SUMO E2 ligase Ubc9; this pathway requires both PACT and PKR and leads to p53 stability, p21 induction, and G1 cell cycle arrest.","method":"Co-expression, dominant-negative PKR, PKR-null MEFs, sumoylation assays, cell cycle analysis","journal":"Cell cycle","confidence":"Medium","confidence_rationale":"Tier 2–3 — genetic epistasis with PKR-null MEFs and sumoylation-deficient p53 mutant, single lab","pmids":["22214662"],"is_preprint":false},{"year":2022,"finding":"CircRNA-CREIT acts as a scaffold to facilitate interaction between PKR and E3 ubiquitin ligase HACE1, promoting K48-linked polyubiquitylation and proteasomal degradation of PKR protein, thereby reducing PKR/eIF2α signaling and stress granule assembly.","method":"RNA pull-down, Co-IP, ubiquitylation assays, western blot, animal models","journal":"Journal of hematology & oncology","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP with ubiquitylation assay showing PTM mechanism, single lab","pmids":["36038948"],"is_preprint":false},{"year":2023,"finding":"CircWDR37 binds to and dimerizes PKR to initiate PKR autophosphorylation; phosphorylated PKR induces IKKβ phosphorylation and releases RELA from IκBα (independent of PKR kinase activity for NF-κB activation) to stimulate NF-κB target gene transcription driving senescence.","method":"RNA pull-down, Co-IP, PKR dimerization assays, IKKβ phosphorylation, NF-κB reporter, kinase-dead mutant","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2–3 — multiple pulldown and phosphorylation assays with mechanistic dissection, single lab","pmids":["36683218"],"is_preprint":false},{"year":2022,"finding":"APOBEC3B forms a complex with PABPC1 to stimulate PKR and counterbalance the PKR-suppressing activity of ADAR1 during viral infection; APOBEC3B localizes to stress granules through interaction with PABPC1 and protects mRNA in stress granules from RNase L-mediated cleavage.","method":"Co-immunoprecipitation, PKR phosphorylation assays, stress granule imaging, RNase L assays","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP with functional follow-up, single lab","pmids":["36781883"],"is_preprint":false},{"year":2020,"finding":"EIF2AK2/PKR is a direct binding target of berberine; berberine inhibits PKR dimerization (rather than its enzymatic activity), selectively modulating downstream JNK, NF-κB, AKT, and NLRP3 pathways; EIF2AK2 knockdown attenuates berberine's anti-inflammatory effects.","method":"Chemoproteomics (thermal shift, DARTS), isothermal titration calorimetry, PKR dimerization assay, EIF2AK2 knockdown mice","journal":"Acta pharmaceutica Sinica. B","confidence":"Medium","confidence_rationale":"Tier 2 — direct target ID by chemoproteomic methods with in vivo knockdown validation, single lab","pmids":["37250154"],"is_preprint":false},{"year":2020,"finding":"Heterozygous de novo missense variants in EIF2AK2 cause reduced kinase activity in patient-derived fibroblasts and mammalian cell lines, resulting in impaired eIF2α phosphorylation; this establishes EIF2AK2 kinase activity as required for normal neurodevelopment.","method":"Patient-derived fibroblasts, heterologous kinase activity assays","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — functional kinase assay in patient-derived cells, multiple probands","pmids":["32197074"],"is_preprint":false},{"year":2023,"finding":"Reduction of renal tubular PNPT1 causes leakage of mitochondrial dsRNA into the cytoplasm, activating PKR and leading to eIF2α phosphorylation and translational arrest; PKR inhibition rescues renal tubular injury in ischemia-reperfusion and ureteral obstruction mouse models.","method":"PKR inhibition (pharmacological and genetic), PNPT1 knockout mice, eIF2α phosphorylation assays, mouse injury models","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — genetic and pharmacological PKR inhibition in vivo with clear pathway placement (PNPT1→mtdsRNA→PKR→eIF2α)","pmids":["36869030"],"is_preprint":false}],"current_model":"EIF2AK2/PKR is an interferon-induced serine/threonine kinase that is activated by dsRNA binding to its N-terminal dsRBD, which relieves autoinhibitory intramolecular interactions and promotes kinase domain dimerization via a conserved salt bridge interface, triggering cis-autophosphorylation on Thr446 and enabling specific recognition and phosphorylation of eIF2α on Ser51 to inhibit global translation; PKR can also be activated by the cellular protein PACT (upon stress-induced phosphorylation), endogenous dsRNAs (mitochondrial RNAs, inverted Alu repeats during mitosis, circRNAs), and heparin, and is negatively regulated by STAT3, TRBP, ADAR1, Hsp90/p23, and circRNA duplexes; beyond translational control, PKR activates NF-κB both kinase-dependently (through phosphorylation) and kinase-independently (by physically interacting with IKKβ and TRAF2/5), promotes inflammasome assembly by interacting with NLRP3/NLRC4/AIM2/ASC, initiates RIP1/RIP3-dependent necroptosis by binding RIP1, and regulates autophagy, mitosis, and apoptosis."},"narrative":{"teleology":[{"year":1999,"claim":"Establishing that PKR is a dsRNA-activated kinase that phosphorylates eIF2α to inhibit translation and activates NF-κB-dependent inflammatory gene transcription provided the foundational dual-function framework for all subsequent mechanistic dissection.","evidence":"Biochemical assays, in vitro kinase assays, and cell-based studies","pmids":["10557102"],"confidence":"High","gaps":["Mechanism of NF-κB activation not resolved","No structural basis for dsRNA-dependent activation"]},{"year":2000,"claim":"Demonstrating that PKR activates NF-κB independently of its kinase activity through physical interaction with IKKβ revealed a scaffolding function distinct from its catalytic role.","evidence":"GST pull-down with kinase-dead PKR mutant, NF-κB reporter assay in PKR-null cells","pmids":["10848580"],"confidence":"High","gaps":["Whether kinase-dependent and kinase-independent NF-κB pathways operate simultaneously in vivo","Stoichiometry of PKR-IKKβ interaction unknown"]},{"year":2001,"claim":"Identifying Hsp90/p23 as a chaperone complex that binds PKR and holds it in a latent state — with dsRNA or Hsp90 inhibitors triggering dissociation and activation — established a negative regulatory mechanism independent of dsRNA-binding competitors.","evidence":"Co-immunoprecipitation, geldanamycin treatment, yeast Hsp90 mutant system","pmids":["11447118"],"confidence":"High","gaps":["Whether Hsp90 regulates PKR stability vs. conformation in vivo","Structural basis of Hsp90-PKR interaction unresolved"]},{"year":2004,"claim":"Mapping PKR's physical interaction with TRAF2 and TRAF5 via a TRAF-interaction motif in the kinase domain, and showing this is required for NF-κB activation, placed PKR within canonical TNF receptor signaling adaptor networks.","evidence":"Co-immunoprecipitation, TRAF-deficient cell lines, dominant-negative expression","pmids":["15121867"],"confidence":"High","gaps":["Whether TRAF and IKKβ interactions are sequential or alternative","Direct ubiquitylation events downstream of PKR-TRAF not characterized"]},{"year":2005,"claim":"Resolving that PKR activation requires catalytic-domain dimerization that triggers Thr446 autophosphorylation, and that helix αG mediates specific eIF2α substrate recognition, provided the structural logic for how dsRNA binding translates into kinase activity.","evidence":"Mutagenesis, in vitro kinase assays, yeast growth suppression, pseudosubstrate binding","pmids":["16179259"],"confidence":"High","gaps":["Full-length PKR crystal structure with dsRNA not available","Kinetics of dimerization vs. autophosphorylation not quantified"]},{"year":2006,"claim":"Two complementary studies established that PKR activation involves both relief of an autoinhibitory intramolecular dsRBD–kinase domain interaction and dsRNA-induced dimerization, showing these are two facets of the same activation mechanism requiring ≥30 bp dsRNA to bridge two PKR monomers.","evidence":"NMR, sedimentation velocity AUC, point mutagenesis, in vitro kinase assays with defined-length dsRNAs","pmids":["16785445","17196820"],"confidence":"High","gaps":["Whether autoinhibition release and dimerization are obligatorily coupled or separable","Dynamics of dsRNA scanning not resolved"]},{"year":2007,"claim":"Identifying the conserved Arg262–Asp266 salt bridge at the PKR dimer interface as essential for all eIF2α kinase family members — with charge-swap rescue confirming the contact — generalized the dimerization mechanism across the family.","evidence":"Charge-swap mutagenesis, yeast functional assay, in vitro kinase assay","pmids":["17202131"],"confidence":"High","gaps":["Whether other eIF2α kinases use identical interface geometry","Allosteric communication from dimer interface to active site not mapped"]},{"year":2008,"claim":"Showing that positively selected residues near PKR's eIF2α binding site confer species-specific sensitivity to poxviral pseudosubstrate inhibitors revealed the evolutionary arms race driving PKR diversification while maintaining substrate specificity.","evidence":"Evolutionary analysis, site-directed mutagenesis, in vitro kinase assays with poxviral inhibitors","pmids":["19043413"],"confidence":"High","gaps":["Whether host-virus co-evolution at this interface drives compensatory eIF2α changes","Structural basis of pseudosubstrate vs. true substrate discrimination"]},{"year":2008,"claim":"Demonstrating that PACT-mediated PKR activation during ER stress requires stress-induced PACT phosphorylation and direct PACT–PKR interaction, with PACT-null and PKR-null cells resistant to ER stress-induced apoptosis, established PACT as a physiological dsRNA-independent PKR activator coupling ER stress to cell death.","evidence":"PACT/PKR null cell lines, cDNA reconstitution, in vitro interaction assays, apoptosis assays, phosphomimetic mutagenesis","pmids":["19007793","19580324"],"confidence":"High","gaps":["Identity of the kinase(s) that phosphorylate PACT domain 3 serines under ER stress","Whether PACT also induces PKR dimerization or uses a distinct activation mode"]},{"year":2010,"claim":"Demonstrating that PKR distinguishes uridine- from pseudouridine-containing mRNA — with pseudouridine preventing PKR binding and activation — revealed a chemical basis for innate immune discrimination of self vs. non-self RNA that later informed mRNA therapeutic design.","evidence":"RNA pull-down, in vitro kinase assay, PKR knockout cell validation","pmids":["20457754"],"confidence":"High","gaps":["Whether other base modifications similarly modulate PKR recognition","In vivo stoichiometry of PKR-mRNA encounters not quantified"]},{"year":2011,"claim":"Showing that heparin activates PKR by binding the kinase domain (not dsRBD) and allosterically enhancing dimerization identified a structurally distinct, non-RNA activation mode and expanded the repertoire of PKR ligands.","evidence":"Analytical ultracentrifugation, in vitro autophosphorylation, thermodynamic linkage analysis","pmids":["21978664"],"confidence":"High","gaps":["Physiological relevance of heparin-PKR interaction in vivo unclear","Structural details of heparin binding site not resolved"]},{"year":2012,"claim":"Three studies in 2012 expanded PKR's cellular roles beyond translation: PKR was shown to physically interact with multiple inflammasome sensors (NLRP3, AIM2, NLRC4, ASC) and be required for inflammasome assembly; STAT3 was identified as a direct inhibitor of PKR autophosphorylation; and PKR was linked to p53 sumoylation and cell cycle arrest during ER stress.","evidence":"Cell-free inflammasome reconstitution with PKR KO; recombinant STAT3 pull-down with domain mutants; PKR-null MEFs with sumoylation assays","pmids":["22801494","23084476","22214662"],"confidence":"High","gaps":["The 2016 kinase-dead knock-in study contradicted PKR as a positive inflammasome regulator, creating unresolved controversy","Direct phosphorylation targets linking PKR to inflammasome assembly not identified","Whether STAT3 inhibition of PKR operates in all cell types"]},{"year":2013,"claim":"Two findings in 2013 refined the activation mechanism and expanded downstream effectors: dimerization-induced cis-phosphorylation of Thr446 was shown to be the obligate activation step, and PKR was found to interact with RIP1 to initiate necroptosis when caspases are inactive.","evidence":"Engineered bypass mutants in yeast with in vitro kinase assays; Co-IP with PKR-deficient cells and kinase-dead mutants","pmids":["24338483","23898178"],"confidence":"High","gaps":["Whether PKR directly phosphorylates RIP1 or acts as a scaffold for necrosome formation","Structural basis for cis- vs. trans-autophosphorylation not fully resolved"]},{"year":2014,"claim":"Discovery that PKR is activated during normal mitosis by inverted Alu repeat dsRNAs released upon nuclear envelope breakdown — suppressing translation and regulating mitotic progression — established a physiological, non-pathogen-related function for PKR in cell division.","evidence":"RNAi knockdown, dominant-negative mutant, dsRNA immunoprecipitation, live-cell imaging, flow cytometry","pmids":["24939934"],"confidence":"High","gaps":["How mitotic PKR activation is terminated after cytokinesis","Whether other endogenous dsRNA sensors also respond to IRAlus during mitosis"]},{"year":2014,"claim":"Identification of DHX36 as an ATPase/helicase that forms a dsRNA-dependent complex with PKR and facilitates its phosphorylation connected PKR activation to RNA helicase-mediated dsRNA processing and stress granule/RIG-I signaling.","evidence":"Co-immunoprecipitation, DHX36 knockout inducible MEFs, PKR phosphorylation assays","pmids":["24651521"],"confidence":"High","gaps":["Whether DHX36 remodels dsRNA structure to enhance PKR binding or stabilizes the PKR-dsRNA complex","Generalizability to other DEAH-box helicases"]},{"year":2015,"claim":"Identifying snoRNAs as PKR-binding activators after metabolic stress broadened the endogenous RNA activator repertoire beyond canonical dsRNA and Alu repeats.","evidence":"RIP-Seq, UV crosslinking IP, in vitro PKR activation assay, snoRNA transfection","pmids":["25848059"],"confidence":"High","gaps":["Which snoRNA structural features are sufficient for PKR activation","Whether snoRNA-PKR interaction occurs under non-metabolic stress conditions"]},{"year":2016,"claim":"Using kinase-dead knock-in and PKR-null mice, a contradictory finding showed that PKR kinase activity represses NLRP3 inflammasome priming by inhibiting translation of inflammasome constituents, directly opposing the 2012 report of PKR as a positive inflammasome activator.","evidence":"Kinase-dead PKR knock-in mouse, PKR-null mouse, inflammasome activity assays","pmids":["26794869"],"confidence":"High","gaps":["Reconciliation of opposing inflammasome findings remains unresolved — may reflect cell type, stimulus, or kinetics differences","Whether scaffolding vs. kinase functions of PKR have opposing effects on inflammasome"]},{"year":2018,"claim":"Three 2018 studies expanded the network of endogenous PKR regulators: mitochondrial dsRNAs formed by bidirectional transcription were identified as constitutive PKR ligands held in check by phosphatases; stress-induced TRBP phosphorylation was shown to enhance its PKR-inhibitory function; and PACT was placed genetically upstream of PKR in stress granule formation via TIA1/TIAL1 epistasis.","evidence":"fCLIP-seq with functional validation; TRBP phospho-mutant Co-IP; PAR-CLIP with double KO and genetic rescue","pmids":["30174290","29348664","29429924"],"confidence":"High","gaps":["Identity of the phosphatases that counteract mtdsRNA-induced PKR activation","Whether TRBP and PACT compete for the same PKR binding site","Quantitative contribution of mtdsRNA vs. nuclear dsRNA to basal PKR activity"]},{"year":2019,"claim":"Endogenous circRNAs were identified as tonic PKR inhibitors through short imperfect dsRNA duplexes, with RNase L-mediated circRNA degradation during viral infection required for PKR derepression — linking circRNA metabolism to innate immune activation and providing a mechanism relevant to SLE autoimmunity.","evidence":"Cellular overexpression/knockdown, RNase L degradation assays, PKR phosphorylation analysis in patient PBMCs","pmids":["31031002"],"confidence":"High","gaps":["Which specific circRNAs are the dominant PKR suppressors in different tissues","Whether circRNA-PKR inhibition is stoichiometric or catalytic"]},{"year":2020,"claim":"Two findings extended PKR's disease relevance: structured repeat expansion RNAs were shown to activate PKR and promote pathological RAN translation in ALS/FTD models, while de novo EIF2AK2 missense variants causing reduced kinase activity were linked to a neurodevelopmental disorder, establishing PKR as essential for normal brain development.","evidence":"PKR-KO cells and dominant-negative PKR with AAV-mediated inhibition in C9orf72 mice; patient-derived fibroblast kinase assays across multiple probands","pmids":["32690681","32197074"],"confidence":"High","gaps":["Whether PKR-driven RAN translation is eIF2α-dependent or uses an alternative mechanism","Full phenotypic spectrum of EIF2AK2 loss-of-function in humans not defined","Whether neurodevelopmental pathology reflects translational control, NF-κB, or other PKR effector arm"]},{"year":2022,"claim":"Live-cell imaging revealed that PKR forms dynamic cytoplasmic condensates (dRIFs/clusters) upon dsRNA stimulation that buffer eIF2α phosphorylation — with eIF2α excluded from clusters and cluster disruption enhancing ISR signaling — introducing a phase-separation/clustering layer to PKR regulation.","evidence":"Live-cell imaging, mutagenesis, eIF2α phosphorylation assays, dsRNA stimulation","pmids":["35939694","35522180"],"confidence":"High","gaps":["Material properties (liquid vs. gel) of dRIFs not characterized","Whether dRIF formation occurs at physiological PKR concentrations in primary cells","Relationship between dRIFs and canonical stress granules not fully resolved"]},{"year":2023,"claim":"In vivo epistasis in triple-knockout mice demonstrated that ADAR1p150 prevents PKR activation via dsRNA binding (editing-independent), while ADAR1 editing prevents MDA5 activation — with combined MDA5/PKR deletion fully rescuing Adar1p150 embryonic lethality — definitively separating ADAR1's editing and PKR-inhibitory functions.","evidence":"Triple knockout mouse genetics, epistasis analysis","pmids":["37797622"],"confidence":"High","gaps":["Whether ADAR1p150 sequesters dsRNA from PKR or directly contacts PKR on dsRNA","Tissue-specific contributions of ADAR1-PKR vs. ADAR1-MDA5 axes"]},{"year":2024,"claim":"Mapping the direct ADAR1 dsRBD3–PKR kinase domain contact surface on dsRNA — with mutagenesis abolishing interaction, co-localization, and PKR inhibition while editing-inactive ADAR1 retained inhibitory activity — resolved that ADAR1 inhibits PKR through a direct protein-protein interaction on dsRNA rather than by editing away dsRNA substrates.","evidence":"AlphaFold structural modeling, mutagenesis, Co-IP, in vivo/in vitro PKR phosphorylation assays","pmids":["39146181"],"confidence":"High","gaps":["Crystal structure of the ternary ADAR1-dsRNA-PKR complex not yet determined","Whether this contact surface is targetable for therapeutic modulation of PKR in autoimmune disease"]},{"year":null,"claim":"Key unresolved questions include: the structural basis of full-length PKR bound to dsRNA; whether PKR's opposing roles in inflammasome regulation reflect cell-type or stimulus-specific contexts; the mechanism by which PKR condensates buffer ISR signaling; and whether PKR's scaffolding vs. kinase functions can be selectively targeted therapeutically.","evidence":"","pmids":[],"confidence":"Low","gaps":["No full-length PKR-dsRNA co-crystal structure","Inflammasome promotion vs. repression controversy unresolved","Phase separation mechanism and physiological relevance of dRIFs need reconstitution","Selective targeting of scaffolding vs. kinase activity not demonstrated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,5,6,17,23]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[3,4,12,13,14,15,20]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[7,8,10,11,29]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[7,8,28]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,14,24,25]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[24]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,7,8,10,11,12,26,27]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1,6,13,14,15,29]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[11,18]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[12,15,20]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[7,8,9,28,35]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[9,16,18,24]}],"complexes":[],"partners":["EIF2S1","PRKRA","ADAR","TRAF2","IKBKB","DHX36","RIPK1","NLRP3"],"other_free_text":[]},"mechanistic_narrative":"EIF2AK2 (PKR) is an interferon-induced serine/threonine kinase that serves as a central cytoplasmic sensor of double-stranded RNA, integrating pathogen detection, endogenous RNA surveillance, and cellular stress into translational control, innate immune signaling, and cell fate decisions. Activation occurs when dsRNA (≥30 bp) or the stress-responsive protein PACT binds the N-terminal dsRNA-binding domain, relieving an autoinhibitory intramolecular interaction between the dsRBD and kinase domain, thereby promoting kinase-domain dimerization through a conserved Arg262–Asp266 salt bridge and cis-autophosphorylation of Thr446 in the activation loop, which enables specific phosphorylation of eIF2α on Ser51 to suppress global translation [PMID:16179259, PMID:16785445, PMID:18599071, PMID:17202131, PMID:24338483]. PKR is negatively regulated by ADAR1p150 (via direct dsRBD3–kinase domain contact on dsRNA), STAT3 (SH2-domain interaction with the catalytic domain), TRBP, Hsp90/p23, and endogenous circRNA duplexes, while endogenous activating ligands include mitochondrial dsRNAs, inverted Alu repeat transcripts released during mitosis, snoRNAs, and structured repeat expansion RNAs [PMID:39146181, PMID:23084476, PMID:11447118, PMID:31031002, PMID:30174290, PMID:24939934, PMID:25848059, PMID:32690681]. Beyond translational control, PKR activates NF-κB both kinase-dependently and kinase-independently through physical interactions with IKKβ and TRAF2/5, promotes inflammasome assembly by interacting with NLRP3/NLRC4/AIM2/ASC, initiates RIP1/RIP3-dependent necroptosis, and forms dsRNA-induced cytoplasmic condensates (dRIFs) that buffer downstream integrated stress response signaling [PMID:10848580, PMID:15121867, PMID:22801494, PMID:23898178, PMID:35939694, PMID:35522180]."},"prefetch_data":{"uniprot":{"accession":"P19525","full_name":"Interferon-induced, double-stranded RNA-activated protein kinase","aliases":["Eukaryotic translation initiation factor 2-alpha kinase 2","eIF-2A protein kinase 2","Interferon-inducible RNA-dependent protein kinase","P1/eIF-2A protein kinase","Protein kinase RNA-activated","PKR","Protein kinase R","Tyrosine-protein kinase EIF2AK2","p68 kinase"],"length_aa":551,"mass_kda":62.1,"function":"IFN-induced dsRNA-dependent serine/threonine-protein kinase that phosphorylates the alpha subunit of eukaryotic translation initiation factor 2 (EIF2S1/eIF-2-alpha) and plays a key role in the innate immune response to viral infection (PubMed:18835251, PubMed:19189853, PubMed:19507191, PubMed:21072047, PubMed:21123651, PubMed:22381929, PubMed:22948139, PubMed:23229543). Inhibits viral replication via the integrated stress response (ISR): EIF2S1/eIF-2-alpha phosphorylation in response to viral infection converts EIF2S1/eIF-2-alpha in a global protein synthesis inhibitor, resulting to a shutdown of cellular and viral protein synthesis, while concomitantly initiating the preferential translation of ISR-specific mRNAs, such as the transcriptional activator ATF4 (PubMed:19189853, PubMed:21123651, PubMed:22948139, PubMed:23229543). Exerts its antiviral activity on a wide range of DNA and RNA viruses including hepatitis C virus (HCV), hepatitis B virus (HBV), measles virus (MV) and herpes simplex virus 1 (HHV-1) (PubMed:11836380, PubMed:19189853, PubMed:19840259, PubMed:20171114, PubMed:21710204, PubMed:23115276, PubMed:23399035). Also involved in the regulation of signal transduction, apoptosis, cell proliferation and differentiation: phosphorylates other substrates including p53/TP53, PPP2R5A, DHX9, ILF3, IRS1 and the HHV-1 viral protein US11 (PubMed:11836380, PubMed:19229320, PubMed:22214662). In addition to serine/threonine-protein kinase activity, also has tyrosine-protein kinase activity and phosphorylates CDK1 at 'Tyr-4' upon DNA damage, facilitating its ubiquitination and proteasomal degradation (PubMed:20395957). Either as an adapter protein and/or via its kinase activity, can regulate various signaling pathways (p38 MAP kinase, NF-kappa-B and insulin signaling pathways) and transcription factors (JUN, STAT1, STAT3, IRF1, ATF3) involved in the expression of genes encoding pro-inflammatory cytokines and IFNs (PubMed:22948139, PubMed:23084476, PubMed:23372823). Activates the NF-kappa-B pathway via interaction with IKBKB and TRAF family of proteins and activates the p38 MAP kinase pathway via interaction with MAP2K6 (PubMed:10848580, PubMed:15121867, PubMed:15229216). Can act as both a positive and negative regulator of the insulin signaling pathway (ISP) (PubMed:20685959). Negatively regulates ISP by inducing the inhibitory phosphorylation of insulin receptor substrate 1 (IRS1) at 'Ser-312' and positively regulates ISP via phosphorylation of PPP2R5A which activates FOXO1, which in turn up-regulates the expression of insulin receptor substrate 2 (IRS2) (PubMed:20685959). Can regulate NLRP3 inflammasome assembly and the activation of NLRP3, NLRP1, AIM2 and NLRC4 inflammasomes (PubMed:22801494). Plays a role in the regulation of the cytoskeleton by binding to gelsolin (GSN), sequestering the protein in an inactive conformation away from actin (By similarity)","subcellular_location":"Cytoplasm; Nucleus; Cytoplasm, perinuclear region","url":"https://www.uniprot.org/uniprotkb/P19525/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/EIF2AK2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000055332","cell_line_id":"CID000738","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleolus_gc","grade":1}],"interactors":[{"gene":"DHX9","stoichiometry":0.2},{"gene":"ZNF346","stoichiometry":0.2},{"gene":"STAU1","stoichiometry":0.2},{"gene":"CKAP4","stoichiometry":0.2},{"gene":"FBXO32","stoichiometry":0.2},{"gene":"ZC3H11A","stoichiometry":0.2},{"gene":"ADAR","stoichiometry":0.2},{"gene":"ILF3","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000738","total_profiled":1310},"omim":[{"mim_id":"619687","title":"DYSTONIA 33; DYT33","url":"https://www.omim.org/entry/619687"},{"mim_id":"618878","title":"LEUKOENCEPHALOPATHY, MOTOR DELAY, SPASTICITY, AND DYSARTHRIA SYNDROME; LEMSPAD","url":"https://www.omim.org/entry/618878"},{"mim_id":"618877","title":"LEUKOENCEPHALOPATHY, DEVELOPMENTAL DELAY, AND EPISODIC NEUROLOGIC REGRESSION SYNDROME; LEUDEN","url":"https://www.omim.org/entry/618877"},{"mim_id":"617458","title":"PRKR-INTERACTING PROTEIN 1, IL11-INDUCIBLE; PRKRIP1","url":"https://www.omim.org/entry/617458"},{"mim_id":"616097","title":"UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX ASSEMBLY FACTOR 3; UQCC3","url":"https://www.omim.org/entry/616097"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Cytosol","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/EIF2AK2"},"hgnc":{"alias_symbol":["PKR","PPP1R83"],"prev_symbol":["PRKR"]},"alphafold":{"accession":"P19525","domains":[{"cath_id":"3.30.160.20","chopping":"10-78","consensus_level":"high","plddt":84.6616,"start":10,"end":78},{"cath_id":"3.30.160.20","chopping":"102-169","consensus_level":"high","plddt":80.5637,"start":102,"end":169},{"cath_id":"3.30.200.20","chopping":"262-338_358-368","consensus_level":"high","plddt":91.1343,"start":262,"end":368},{"cath_id":"1.10.510.10","chopping":"373-542","consensus_level":"high","plddt":92.0311,"start":373,"end":542}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P19525","model_url":"https://alphafold.ebi.ac.uk/files/AF-P19525-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P19525-F1-predicted_aligned_error_v6.png","plddt_mean":76.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=EIF2AK2","jax_strain_url":"https://www.jax.org/strain/search?query=EIF2AK2"},"sequence":{"accession":"P19525","fasta_url":"https://rest.uniprot.org/uniprotkb/P19525.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P19525/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P19525"}},"corpus_meta":[{"pmid":"10557102","id":"PMC_10557102","title":"PKR; a sentinel kinase for cellular stress.","date":"1999","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10557102","citation_count":669,"is_preprint":false},{"pmid":"31031002","id":"PMC_31031002","title":"Structure and Degradation of Circular RNAs Regulate PKR Activation in Innate Immunity.","date":"2019","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/31031002","citation_count":652,"is_preprint":false},{"pmid":"22801494","id":"PMC_22801494","title":"Novel role of PKR in inflammasome activation and HMGB1 release.","date":"2012","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22801494","citation_count":639,"is_preprint":false},{"pmid":"20457754","id":"PMC_20457754","title":"Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation.","date":"2010","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/20457754","citation_count":511,"is_preprint":false},{"pmid":"11752661","id":"PMC_11752661","title":"Signal integration via PKR.","date":"2001","source":"Science's STKE : signal transduction knowledge environment","url":"https://pubmed.ncbi.nlm.nih.gov/11752661","citation_count":314,"is_preprint":false},{"pmid":"11232238","id":"PMC_11232238","title":"Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action.","date":"2000","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/11232238","citation_count":304,"is_preprint":false},{"pmid":"16179259","id":"PMC_16179259","title":"Mechanistic link between PKR dimerization, autophosphorylation, and eIF2alpha substrate recognition.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16179259","citation_count":301,"is_preprint":false},{"pmid":"23898178","id":"PMC_23898178","title":"Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23898178","citation_count":300,"is_preprint":false},{"pmid":"23084476","id":"PMC_23084476","title":"Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/23084476","citation_count":232,"is_preprint":false},{"pmid":"30686999","id":"PMC_30686999","title":"PKR: A Kinase to Remember.","date":"2019","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30686999","citation_count":213,"is_preprint":false},{"pmid":"7631421","id":"PMC_7631421","title":"PKR: a new name and new roles.","date":"1995","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/7631421","citation_count":207,"is_preprint":false},{"pmid":"30174290","id":"PMC_30174290","title":"PKR Senses Nuclear and Mitochondrial Signals by Interacting with Endogenous Double-Stranded RNAs.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30174290","citation_count":196,"is_preprint":false},{"pmid":"10848580","id":"PMC_10848580","title":"PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10848580","citation_count":194,"is_preprint":false},{"pmid":"18599071","id":"PMC_18599071","title":"Mechanism of PKR Activation by dsRNA.","date":"2008","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18599071","citation_count":168,"is_preprint":false},{"pmid":"36038948","id":"PMC_36038948","title":"CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR.","date":"2022","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36038948","citation_count":148,"is_preprint":false},{"pmid":"22306812","id":"PMC_22306812","title":"Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway.","date":"2012","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22306812","citation_count":144,"is_preprint":false},{"pmid":"7537157","id":"PMC_7537157","title":"Regulation of the interferon-induced PKR: can viruses cope?","date":"1995","source":"Trends in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/7537157","citation_count":142,"is_preprint":false},{"pmid":"11904369","id":"PMC_11904369","title":"Regulation of PKR and IRF-1 during hepatitis C virus RNA replication.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11904369","citation_count":139,"is_preprint":false},{"pmid":"24651521","id":"PMC_24651521","title":"DHX36 enhances RIG-I signaling by facilitating PKR-mediated antiviral stress granule formation.","date":"2014","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/24651521","citation_count":129,"is_preprint":false},{"pmid":"34951963","id":"PMC_34951963","title":"RNA circles with minimized immunogenicity as potent PKR inhibitors.","date":"2021","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/34951963","citation_count":126,"is_preprint":false},{"pmid":"17196820","id":"PMC_17196820","title":"Activation of PKR: an open and shut case?","date":"2006","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17196820","citation_count":124,"is_preprint":false},{"pmid":"15121867","id":"PMC_15121867","title":"TRAF family proteins link PKR with NF-kappa B activation.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15121867","citation_count":121,"is_preprint":false},{"pmid":"24939934","id":"PMC_24939934","title":"PKR is activated by cellular dsRNAs during mitosis and acts as a mitotic regulator.","date":"2014","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/24939934","citation_count":119,"is_preprint":false},{"pmid":"32690681","id":"PMC_32690681","title":"Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS/FTD mice.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32690681","citation_count":113,"is_preprint":false},{"pmid":"16785445","id":"PMC_16785445","title":"Molecular basis for PKR activation by PACT or dsRNA.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16785445","citation_count":108,"is_preprint":false},{"pmid":"19043413","id":"PMC_19043413","title":"Rapid evolution of protein kinase PKR alters sensitivity to viral inhibitors.","date":"2008","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19043413","citation_count":106,"is_preprint":false},{"pmid":"21994559","id":"PMC_21994559","title":"Activation of the Antiviral Kinase PKR and Viral Countermeasures.","date":"2009","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/21994559","citation_count":97,"is_preprint":false},{"pmid":"25848059","id":"PMC_25848059","title":"Potential role for snoRNAs in PKR activation during metabolic stress.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25848059","citation_count":97,"is_preprint":false},{"pmid":"11447118","id":"PMC_11447118","title":"The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA-dependent kinase PKR.","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11447118","citation_count":96,"is_preprint":false},{"pmid":"29429924","id":"PMC_29429924","title":"The TIA1 RNA-Binding Protein Family Regulates EIF2AK2-Mediated Stress Response and Cell Cycle Progression.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29429924","citation_count":95,"is_preprint":false},{"pmid":"24522206","id":"PMC_24522206","title":"The impact of PKR activation: from neurodegeneration to cancer.","date":"2014","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/24522206","citation_count":84,"is_preprint":false},{"pmid":"23092889","id":"PMC_23092889","title":"PKR-dependent inflammatory signals.","date":"2012","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/23092889","citation_count":84,"is_preprint":false},{"pmid":"37797622","id":"PMC_37797622","title":"ADAR1p150 prevents MDA5 and PKR activation via distinct mechanisms to avert fatal autoinflammation.","date":"2023","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/37797622","citation_count":79,"is_preprint":false},{"pmid":"18418049","id":"PMC_18418049","title":"PERK and PKR: old kinases learn new tricks.","date":"2008","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/18418049","citation_count":78,"is_preprint":false},{"pmid":"34759908","id":"PMC_34759908","title":"Inhibition of PKR by Viruses.","date":"2021","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/34759908","citation_count":75,"is_preprint":false},{"pmid":"19445956","id":"PMC_19445956","title":"RNA dimerization promotes PKR dimerization and activation.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19445956","citation_count":69,"is_preprint":false},{"pmid":"21294215","id":"PMC_21294215","title":"Multiple levels of PKR inhibition during HIV-1 replication.","date":"2010","source":"Reviews in medical virology","url":"https://pubmed.ncbi.nlm.nih.gov/21294215","citation_count":64,"is_preprint":false},{"pmid":"10899117","id":"PMC_10899117","title":"Potential role of PKR in double-stranded RNA-induced macrophage activation.","date":"2000","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10899117","citation_count":64,"is_preprint":false},{"pmid":"28982375","id":"PMC_28982375","title":"PKR involvement in Alzheimer's disease.","date":"2017","source":"Alzheimer's research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/28982375","citation_count":63,"is_preprint":false},{"pmid":"37250154","id":"PMC_37250154","title":"Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects.","date":"2022","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/37250154","citation_count":62,"is_preprint":false},{"pmid":"24020926","id":"PMC_24020926","title":"The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication.","date":"2013","source":"Retrovirology","url":"https://pubmed.ncbi.nlm.nih.gov/24020926","citation_count":60,"is_preprint":false},{"pmid":"32197074","id":"PMC_32197074","title":"De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation.","date":"2020","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32197074","citation_count":59,"is_preprint":false},{"pmid":"24150608","id":"PMC_24150608","title":"Small-molecule inhibitors of PKR improve glucose homeostasis in obese diabetic mice.","date":"2013","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/24150608","citation_count":59,"is_preprint":false},{"pmid":"7893827","id":"PMC_7893827","title":"Proteins that interact with PKR.","date":"1994","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/7893827","citation_count":57,"is_preprint":false},{"pmid":"33387379","id":"PMC_33387379","title":"A tale of two proteins: PACT and PKR and their roles in inflammation.","date":"2021","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/33387379","citation_count":55,"is_preprint":false},{"pmid":"31772125","id":"PMC_31772125","title":"PKR-dependent cytosolic cGAS foci are necessary for intracellular DNA sensing.","date":"2019","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/31772125","citation_count":54,"is_preprint":false},{"pmid":"24684861","id":"PMC_24684861","title":"Activation of the PKR/eIF2α signaling cascade inhibits replication of Newcastle disease virus.","date":"2014","source":"Virology journal","url":"https://pubmed.ncbi.nlm.nih.gov/24684861","citation_count":53,"is_preprint":false},{"pmid":"23221979","id":"PMC_23221979","title":"Direct interaction between STAT3 and EIF2AK2 controls fatty acid-induced autophagy.","date":"2012","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/23221979","citation_count":52,"is_preprint":false},{"pmid":"28869834","id":"PMC_28869834","title":"PKR activation causes inflammation and MMP-13 secretion in human degenerated articular chondrocytes.","date":"2017","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/28869834","citation_count":51,"is_preprint":false},{"pmid":"18217692","id":"PMC_18217692","title":"PKR in innate immunity, cancer, and viral oncolysis.","date":"2007","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/18217692","citation_count":50,"is_preprint":false},{"pmid":"35939694","id":"PMC_35939694","title":"dsRNA-induced condensation of antiviral proteins modulates PKR activity.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35939694","citation_count":49,"is_preprint":false},{"pmid":"24338483","id":"PMC_24338483","title":"Activation of protein kinase PKR requires dimerization-induced cis-phosphorylation within the activation loop.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24338483","citation_count":49,"is_preprint":false},{"pmid":"17202131","id":"PMC_17202131","title":"Conserved intermolecular salt bridge required for activation of protein kinases PKR, GCN2, and PERK.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17202131","citation_count":49,"is_preprint":false},{"pmid":"20447405","id":"PMC_20447405","title":"Regulation of PKR by HCV IRES RNA: importance of domain II and NS5A.","date":"2010","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20447405","citation_count":48,"is_preprint":false},{"pmid":"36683218","id":"PMC_36683218","title":"Chemotherapy-Induced Senescence Reprogramming Promotes Nasopharyngeal Carcinoma Metastasis by circRNA-Mediated PKR Activation.","date":"2023","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/36683218","citation_count":43,"is_preprint":false},{"pmid":"22275310","id":"PMC_22275310","title":"PKR protects colonic epithelium against colitis through the unfolded protein response and prosurvival signaling.","date":"2012","source":"Inflammatory bowel diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22275310","citation_count":43,"is_preprint":false},{"pmid":"21418572","id":"PMC_21418572","title":"Characterization of a ranavirus inhibitor of the antiviral protein kinase PKR.","date":"2011","source":"BMC microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/21418572","citation_count":42,"is_preprint":false},{"pmid":"19007793","id":"PMC_19007793","title":"Essential role of PACT-mediated PKR activation in tunicamycin-induced apoptosis.","date":"2008","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19007793","citation_count":42,"is_preprint":false},{"pmid":"32508669","id":"PMC_32508669","title":"Metformin Ameliorates Diabetic Cardiomyopathy by Activating the PK2/PKR Pathway.","date":"2020","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32508669","citation_count":41,"is_preprint":false},{"pmid":"29348664","id":"PMC_29348664","title":"Stress-induced TRBP phosphorylation enhances its interaction with PKR to regulate cellular survival.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29348664","citation_count":41,"is_preprint":false},{"pmid":"22214662","id":"PMC_22214662","title":"The RAX/PACT-PKR stress response pathway promotes p53 sumoylation and activation, leading to G₁ arrest.","date":"2012","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/22214662","citation_count":40,"is_preprint":false},{"pmid":"35858300","id":"PMC_35858300","title":"Viral evasion of PKR restriction by reprogramming cellular stress granules.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35858300","citation_count":39,"is_preprint":false},{"pmid":"28341446","id":"PMC_28341446","title":"PKR induces the expression of NLRP3 by regulating the NF-κB pathway in Porphyromonas gingivalis-infected osteoblasts.","date":"2017","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/28341446","citation_count":39,"is_preprint":false},{"pmid":"20585572","id":"PMC_20585572","title":"Role of PKR and Type I IFNs in viral control during primary and secondary infection.","date":"2010","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/20585572","citation_count":39,"is_preprint":false},{"pmid":"35708211","id":"PMC_35708211","title":"YTHDF3 Facilitates eIF2AK2 and eIF3A Recruitment on mRNAs to Regulate Translational Processes in Oxaliplatin-Resistant Colorectal Cancer.","date":"2022","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/35708211","citation_count":37,"is_preprint":false},{"pmid":"25590804","id":"PMC_25590804","title":"PKR downregulation prevents neurodegeneration and β-amyloid production in a thiamine-deficient model.","date":"2015","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/25590804","citation_count":36,"is_preprint":false},{"pmid":"35522180","id":"PMC_35522180","title":"Signaling by the integrated stress response kinase PKR is fine-tuned by dynamic clustering.","date":"2022","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/35522180","citation_count":34,"is_preprint":false},{"pmid":"26052716","id":"PMC_26052716","title":"Serum Amyloid A Stimulates PKR Expression and HMGB1 Release Possibly through TLR4/RAGE Receptors.","date":"2015","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/26052716","citation_count":34,"is_preprint":false},{"pmid":"29486283","id":"PMC_29486283","title":"Musashi-1 promotes chemoresistant granule formation by PKR/eIF2α signalling cascade in refractory glioblastoma.","date":"2018","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/29486283","citation_count":34,"is_preprint":false},{"pmid":"36781883","id":"PMC_36781883","title":"APOBEC3B drives PKR-mediated translation shutdown and protects stress granules in response to viral infection.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36781883","citation_count":33,"is_preprint":false},{"pmid":"26794869","id":"PMC_26794869","title":"The kinase activity of PKR represses inflammasome activity.","date":"2016","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/26794869","citation_count":33,"is_preprint":false},{"pmid":"29625900","id":"PMC_29625900","title":"ADAR1 and PKR, interferon stimulated genes with clashing effects on HIV-1 replication.","date":"2018","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/29625900","citation_count":32,"is_preprint":false},{"pmid":"11752660","id":"PMC_11752660","title":"PACT and PKR: turning on NF-kappa B in the absence of virus.","date":"2001","source":"Science's STKE : signal transduction knowledge environment","url":"https://pubmed.ncbi.nlm.nih.gov/11752660","citation_count":31,"is_preprint":false},{"pmid":"27612419","id":"PMC_27612419","title":"nc886, a non-coding RNA and suppressor of PKR, exerts an oncogenic function in thyroid cancer.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27612419","citation_count":31,"is_preprint":false},{"pmid":"27021640","id":"PMC_27021640","title":"IRE1α mediates PKR activation in response to Chlamydia trachomatis infection.","date":"2016","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/27021640","citation_count":31,"is_preprint":false},{"pmid":"23403623","id":"PMC_23403623","title":"PKR regulates proliferation, differentiation, and survival of murine hematopoietic stem/progenitor cells.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23403623","citation_count":31,"is_preprint":false},{"pmid":"21978664","id":"PMC_21978664","title":"Heparin activates PKR by inducing dimerization.","date":"2011","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21978664","citation_count":29,"is_preprint":false},{"pmid":"9735304","id":"PMC_9735304","title":"RNA binding and modulation of PKR activity.","date":"1998","source":"Methods (San Diego, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/9735304","citation_count":29,"is_preprint":false},{"pmid":"32539931","id":"PMC_32539931","title":"Hepatitis C virus exploits cyclophilin A to evade PKR.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32539931","citation_count":29,"is_preprint":false},{"pmid":"19580324","id":"PMC_19580324","title":"Biochemical analysis of PKR activation by PACT.","date":"2009","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19580324","citation_count":29,"is_preprint":false},{"pmid":"29906232","id":"PMC_29906232","title":"Novel role of PKR in palmitate-induced Sirt1 inactivation and endothelial cell senescence.","date":"2018","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29906232","citation_count":28,"is_preprint":false},{"pmid":"33588244","id":"PMC_33588244","title":"EIF2AK2 selectively regulates the gene transcription in immune response and histones associated with systemic lupus erythematosus.","date":"2021","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33588244","citation_count":27,"is_preprint":false},{"pmid":"10684936","id":"PMC_10684936","title":"A new double-stranded RNA-binding protein that interacts with PKR.","date":"2000","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/10684936","citation_count":27,"is_preprint":false},{"pmid":"26725122","id":"PMC_26725122","title":"NIPBL Controls RNA Biogenesis to Prevent Activation of the Stress Kinase PKR.","date":"2015","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26725122","citation_count":26,"is_preprint":false},{"pmid":"27994435","id":"PMC_27994435","title":"PKR promotes choroidal neovascularization via upregulating the PI3K/Akt signaling pathway in VEGF expression.","date":"2016","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/27994435","citation_count":26,"is_preprint":false},{"pmid":"36869030","id":"PMC_36869030","title":"Polynucleotide phosphorylase protects against renal tubular injury via blocking mt-dsRNA-PKR-eIF2α axis.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36869030","citation_count":25,"is_preprint":false},{"pmid":"25064266","id":"PMC_25064266","title":"HIV-1 translation and its regulation by cellular factors PKR and PACT.","date":"2014","source":"Virus research","url":"https://pubmed.ncbi.nlm.nih.gov/25064266","citation_count":25,"is_preprint":false},{"pmid":"24334130","id":"PMC_24334130","title":"Inhibition of PKR protects against tunicamycin-induced apoptosis in neuroblastoma cells.","date":"2013","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/24334130","citation_count":25,"is_preprint":false},{"pmid":"26488609","id":"PMC_26488609","title":"Regulation of PKR by RNA: formation of active and inactive dimers.","date":"2015","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26488609","citation_count":24,"is_preprint":false},{"pmid":"33984068","id":"PMC_33984068","title":"Human DICER helicase domain recruits PKR and modulates its antiviral activity.","date":"2021","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/33984068","citation_count":24,"is_preprint":false},{"pmid":"31292248","id":"PMC_31292248","title":"The Leader Protein of Theiler's Virus Prevents the Activation of PKR.","date":"2019","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/31292248","citation_count":24,"is_preprint":false},{"pmid":"27004760","id":"PMC_27004760","title":"Enterovirus 71 induces dsRNA/PKR-dependent cytoplasmic redistribution of GRP78/BiP to promote viral replication.","date":"2016","source":"Emerging microbes & infections","url":"https://pubmed.ncbi.nlm.nih.gov/27004760","citation_count":24,"is_preprint":false},{"pmid":"28008894","id":"PMC_28008894","title":"The Specific Protein Kinase R (PKR) Inhibitor C16 Protects Neonatal Hypoxia-Ischemia Brain Damages by Inhibiting Neuroinflammation in a Neonatal Rat Model.","date":"2016","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/28008894","citation_count":24,"is_preprint":false},{"pmid":"28611419","id":"PMC_28611419","title":"Interaction of PKR with single-stranded RNA.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28611419","citation_count":23,"is_preprint":false},{"pmid":"30518569","id":"PMC_30518569","title":"The Noncoding RNA nc886 Regulates PKR Signaling and Cytokine Production in Human Cells.","date":"2018","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/30518569","citation_count":23,"is_preprint":false},{"pmid":"32665273","id":"PMC_32665273","title":"eIF2B as a Target for Viral Evasion of PKR-Mediated Translation Inhibition.","date":"2020","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/32665273","citation_count":23,"is_preprint":false},{"pmid":"23601785","id":"PMC_23601785","title":"Double-stranded RNA binding by the human cytomegalovirus PKR antagonist TRS1.","date":"2013","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/23601785","citation_count":23,"is_preprint":false},{"pmid":"39311631","id":"PMC_39311631","title":"EIF2AK2 protein targeted activation of AIM2-mediated PANoptosis promotes sepsis-induced acute kidney injury.","date":"2024","source":"Renal failure","url":"https://pubmed.ncbi.nlm.nih.gov/39311631","citation_count":22,"is_preprint":false},{"pmid":"27486347","id":"PMC_27486347","title":"Oncogenes: The Passport for Viral Oncolysis Through PKR Inhibition.","date":"2016","source":"Biomarkers in cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27486347","citation_count":22,"is_preprint":false},{"pmid":"39146181","id":"PMC_39146181","title":"An ADAR1 dsRBD3-PKR kinase domain interaction on dsRNA inhibits PKR activation.","date":"2024","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/39146181","citation_count":21,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45092,"output_tokens":8530,"usd":0.131613},"stage2":{"model":"claude-opus-4-6","input_tokens":12594,"output_tokens":5782,"usd":0.31128},"total_usd":0.442893,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"PKR (EIF2AK2) is autophosphorylated and activated upon binding to dsRNA, leading to phosphorylation of eIF2α and inhibition of protein synthesis; PKR also induces transcription of inflammatory genes via activation of NF-κB and other transcription factors.\",\n      \"method\": \"Biochemical assays, in vitro kinase assays, cell-based studies\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — foundational mechanism replicated across many labs, multiple orthogonal methods\",\n      \"pmids\": [\"10557102\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PKR activation requires catalytic-domain dimerization, which triggers Thr446 autophosphorylation within the activation segment; helix αG is critical for specific recognition of eIF2α substrate; mutations on the dimerization surface block autophosphorylation and eIF2α phosphorylation.\",\n      \"method\": \"Mutagenesis, in vitro kinase assays, yeast growth suppression, pseudosubstrate binding\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with mutagenesis and functional validation in a single rigorous study\",\n      \"pmids\": [\"16179259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PKR activation by dsRNA or PACT is mediated by relief of an intramolecular autoinhibitory interaction between the kinase domain PACT-binding motif (PBM) and the dsRNA-binding domain; disruption of this interaction by mutations or a decoy PBM peptide constitutively activates PKR.\",\n      \"method\": \"NMR, biochemical assays, point mutagenesis, in vitro kinase assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structural analysis combined with mutagenesis and functional biochemical validation\",\n      \"pmids\": [\"16785445\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"dsRNA functions primarily to induce dimerization of PKR via the kinase domain rather than solely releasing autoinhibition; a minimum of 30 bp dsRNA is required to bind two PKR monomers and elicit autophosphorylation.\",\n      \"method\": \"Biophysical analyses, sedimentation velocity, in vitro autophosphorylation assays with dsRNAs of varying length\",\n      \"journal\": \"Trends in biochemical sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with biophysical methods, supported by independent structural data\",\n      \"pmids\": [\"17196820\", \"18599071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PKR requires dsRNA of at least 30 bp to bind two monomers and undergo dimerization-driven autophosphorylation; sequential, non-cooperative attachment of PKR monomers to dsRNA leads to dimerization via the kinase domain.\",\n      \"method\": \"Sedimentation velocity analytical ultracentrifugation, in vitro autophosphorylation assays\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative biophysical reconstitution with defined substrates\",\n      \"pmids\": [\"18599071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"A conserved intermolecular salt bridge between Arg262 and Asp266 at the PKR kinase domain dimer interface is essential for PKR activity; charge-swap double mutations restore function, confirming this interface is critical for the eIF2α kinase family.\",\n      \"method\": \"Mutagenesis, yeast functional assay, in vitro kinase assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis with in vitro and in vivo validation, charge-swap rescue experiment\",\n      \"pmids\": [\"17202131\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PKR activation requires dimerization-induced cis-phosphorylation of Thr446 in the activation loop; dimerization precedes and stimulates activation loop autophosphorylation, and these processes are mutually exclusive yet interdependent.\",\n      \"method\": \"Yeast functional system, engineered bypass mutants, in vitro kinase assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — genetic epistasis with in vitro biochemical validation in reconstituted system\",\n      \"pmids\": [\"24338483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"PKR activates NF-κB independent of its kinase activity by physically interacting with the IKKβ subunit of the IKK complex, as demonstrated by GST pull-down and catalytically inactive mutant PKR still activating NF-κB.\",\n      \"method\": \"GST pull-down, co-expression of kinase-dead PKR mutants, NF-κB reporter assay, PKR-null cell reconstitution\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal pulldown with kinase-dead mutant dissecting kinase-dependent vs. -independent functions\",\n      \"pmids\": [\"10848580\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PKR physically interacts with TRAF2 and TRAF5 via a TRAF-interaction motif in its kinase domain; this interaction is induced by PKR dimerization and is required for PKR-mediated NF-κB activation.\",\n      \"method\": \"Co-immunoprecipitation, confocal colocalization, TRAF-deficient cell lines, dominant-negative expression, computer docking\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with TRAF-null epistasis and mutational analysis\",\n      \"pmids\": [\"15121867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The SH2 domain of cytoplasmic STAT3 interacts with the catalytic domain of EIF2AK2/PKR to inhibit its activating autophosphorylation; disruption of this interaction (by STAT3 inhibitors or palmitate) leads to PKR-dependent eIF2α phosphorylation and autophagy induction.\",\n      \"method\": \"Recombinant protein pull-down, co-immunoprecipitation, pharmacological/genetic STAT3 inhibition, PKR knockdown, STAT3 domain mutants\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — recombinant protein interaction confirmed by multiple orthogonal methods including domain mutagenesis\",\n      \"pmids\": [\"23084476\", \"23221979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PKR is required for inflammasome activation in macrophages; PKR autophosphorylation precedes inflammasome assembly, and PKR physically interacts with NLRP3, NLRP1, NLRC4, AIM2, and ASC. Reconstitution of inflammasome activity in a cell-free system with recombinant NLRP3, ASC, and pro-caspase-1 required PKR autophosphorylation.\",\n      \"method\": \"Co-immunoprecipitation, PKR genetic knockout, pharmacological inhibition, cell-free reconstitution assay\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — cell-free reconstitution plus genetic KO with multiple orthogonal methods in high-impact journal\",\n      \"pmids\": [\"22801494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"IFN-induced PKR interacts with RIP1 to initiate necrosome formation and trigger RIP1/RIP3-mediated necrosis when FADD is absent or caspases are inactivated; PKR kinase activity (not RIP1 kinase activity) is required for this process.\",\n      \"method\": \"Co-immunoprecipitation, PKR-deficient cells, kinase-dead mutants, genetic knockouts, live-cell imaging\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with genetic epistasis across multiple knockout cell lines\",\n      \"pmids\": [\"23898178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Endogenous circRNAs form 16–26 bp imperfect RNA duplexes and act as inhibitors of PKR; upon viral infection, RNase L degrades circRNAs, which is required for PKR activation in innate immune responses. Overexpression of dsRNA-containing circRNA alleviates aberrant PKR activation in SLE patient cells.\",\n      \"method\": \"Cellular overexpression/knockdown, RNase L-mediated degradation assays, PKR phosphorylation analysis, patient PBMCs\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (genetic, pharmacological, patient-derived) in high-impact journal\",\n      \"pmids\": [\"31031002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PKR is activated by uridine-containing in vitro transcribed mRNA but not by pseudouridine-containing mRNA; PKR binds uridine-containing mRNA more efficiently, and pseudouridine substitution reduces PKR activation and diminishes eIF2α-mediated translation inhibition.\",\n      \"method\": \"RNA pull-down, in vitro kinase assay, PKR knockout cell validation\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — biochemical binding assay combined with PKR-null cell rescue experiment\",\n      \"pmids\": [\"20457754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PKR is activated during mitosis in uninfected cells by binding to dsRNAs formed by inverted Alu repeats (IRAlus) that become accessible when nuclear structure breaks down; activated pPKR suppresses global translation via eIF2α phosphorylation and regulates JNK, cyclin A/B, PLK1 levels, and histone H3 phosphorylation; PKR disruption causes cytokinesis defects.\",\n      \"method\": \"RNAi knockdown, dominant-negative mutant expression, immunoprecipitation of dsRNA, live-cell imaging, flow cytometry\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods demonstrating both molecular mechanism and cellular phenotype\",\n      \"pmids\": [\"24939934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PKR interacts with endogenous mitochondrial RNAs (mtRNAs) that form intermolecular dsRNAs due to bidirectional transcription; these mtRNAs regulate PKR and eIF2α phosphorylation; PKR activation by mtRNAs is counteracted by PKR phosphatases, and disruption of phosphatases causes apoptosis.\",\n      \"method\": \"Formaldehyde crosslinking and immunoprecipitation sequencing (fCLIP-seq), RNAi knockdown, PKR phosphorylation assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide crosslinking approach combined with functional validation\",\n      \"pmids\": [\"30174290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The Hsp90 chaperone complex (Hsp90 and co-chaperone p23) binds to PKR through both its N-terminal dsRNA-binding region and kinase domain; dsRNA or Hsp90 inhibitors (geldanamycin, radicicol) rapidly dissociate Hsp90/p23 from PKR and activate it, triggering eIF2α phosphorylation.\",\n      \"method\": \"Co-immunoprecipitation, geldanamycin treatment, in vivo and in vitro PKR activation assays, yeast Hsp90 mutant system\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with domain mapping and pharmacological dissection in both yeast and mammalian cells\",\n      \"pmids\": [\"11447118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Stress-induced phosphorylation of specific serine residues in domain 3 of PACT increases its affinity for PKR, leading to PKR autophosphorylation and eIF2α phosphorylation; phosphomimetic aspartate substitutions at these serines enhance PACT-PKR binding and PKR activation in vitro.\",\n      \"method\": \"In vitro binding assays, in vitro kinase assays, phosphomimetic mutagenesis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with quantitative binding measurements and phosphomimetic mutants\",\n      \"pmids\": [\"19580324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PACT-mediated PKR activation via direct protein-protein interaction is essential for ER stress-induced apoptosis; PACT is phosphorylated in response to tunicamycin and activates PKR; PACT-null and PKR-null cells are resistant to ER stress-induced apoptosis with defective eIF2α phosphorylation.\",\n      \"method\": \"PACT/PKR null cell lines, reconstitution with cDNA, in vitro interaction assays, apoptosis assays\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — null cell reconstitution with multiple orthogonal readouts\",\n      \"pmids\": [\"19007793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Heparin activates PKR by binding to the kinase domain (not the dsRNA-binding domain) and allosterically enhancing PKR dimerization, leading to autophosphorylation; heparin hexasaccharides are sufficient for activation.\",\n      \"method\": \"Analytical ultracentrifugation, in vitro autophosphorylation assays, thermodynamic linkage analysis\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biophysical reconstitution with distinct mechanism from dsRNA activation\",\n      \"pmids\": [\"21978664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Small nucleolar RNAs (snoRNAs) interact with PKR after metabolic stress (palmitic acid treatment) via its dsRNA-binding domain; a subset of snoRNAs can bind and activate PKR in vitro, and snoRNA transfection activates PKR in cells.\",\n      \"method\": \"RIP-Seq, UV crosslinking immunoprecipitation with RT-qPCR, in vitro PKR activation assay, snoRNA transfection\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro reconstitution confirmed by cell-based approaches with dsRBD mutant controls\",\n      \"pmids\": [\"25848059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"DHX36 forms a complex with PKR in a dsRNA-dependent manner and facilitates dsRNA binding and phosphorylation of PKR through its ATPase/helicase activity, thereby promoting antiviral stress granule formation and RIG-I signaling.\",\n      \"method\": \"Co-immunoprecipitation, DHX36 knockout inducible MEF cells, PKR phosphorylation assays\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with genetic KO showing physiological relevance\",\n      \"pmids\": [\"24651521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Loss of PRKRA (PACT) by mis-splicing in TIA1/TIAL1 double-knockout cells triggers EIF2AK2/PKR activation and stress granule formation; ectopic PRKRA cDNA or EIF2AK2 knockout rescues this phenotype, placing PRKRA upstream of EIF2AK2 in RNA stress sensing.\",\n      \"method\": \"PAR-CLIP, double gene knockout, genetic rescue with cDNA or knockout\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis confirmed by genetic rescue in both directions\",\n      \"pmids\": [\"29429924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Positively selected residues in the PKR kinase domain near the eIF2α binding site confer species-specific differences in sensitivity to poxviral pseudosubstrate inhibitors; substitution of these residues alters inhibitor sensitivity while maintaining eIF2α phosphorylation activity.\",\n      \"method\": \"Evolutionary analysis, site-directed mutagenesis, in vitro kinase assays with poxviral inhibitors\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis-based functional mapping of eIF2α binding site with in vitro validation\",\n      \"pmids\": [\"19043413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PKR forms dynamic cytosolic condensates (dsRNA-induced foci, dRIFs) in response to elevated dsRNA; dRIFs contain dsRNA and enriched dsRNA-binding proteins (ADAR1, Stau1, NLRP1, PACT); dRIF formation correlates with and precedes PKR activation and translation repression, and dRIF disruption enhances eIF2α phosphorylation.\",\n      \"method\": \"Live-cell imaging, immunofluorescence, eIF2α phosphorylation assays, dsRNA stimulation\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct live-cell localization linked to functional PKR activation with mechanistic follow-up\",\n      \"pmids\": [\"35939694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PKR signaling involves assembly of dynamic PKR clusters driven by ligand binding to the sensor domain and front-to-front interfaces between kinase domains; eIF2α is excluded from PKR clusters, and cluster disruption enhances eIF2α phosphorylation, suggesting clustering buffers downstream ISR signaling.\",\n      \"method\": \"Live-cell imaging, mutagenesis, eIF2α phosphorylation assays, proximity-based approaches\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — novel structural model with functional validation, single lab\",\n      \"pmids\": [\"35522180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ADAR1p150 cytoplasmic isoform prevents PKR activation via its dsRNA-binding activity (editing-independent mechanism), while ADAR1 RNA editing prevents MDA5 activation; deleting both MDA5 and PKR fully rescues embryonic lethality of Adar1p150-/- mice.\",\n      \"method\": \"Triple knockout mouse genetics, epistasis analysis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo epistasis with full phenotypic rescue in mouse model\",\n      \"pmids\": [\"37797622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ADAR1 dsRBD3 directly interacts with the PKR kinase domain on dsRNA to inhibit PKR activation; AlphaFold modeling and mutagenesis of the ADAR1 dsRBD3–PKR contact surface abolish co-immunoprecipitation, PKR inhibition, and co-localization; editing-inactive ADAR1 retains PKR-inhibitory activity but dsRNA binding is required.\",\n      \"method\": \"Co-immunoprecipitation, AlphaFold structural modeling, mutagenesis, in vivo/in vitro PKR phosphorylation assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — structural model with mutagenesis validation, reciprocal Co-IP, and functional assays\",\n      \"pmids\": [\"39146181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PKR promotes cGAS condensation and DNA sensing by an RNA-dependent association with G3BP1 to facilitate G3BP1 foci formation; loss of G3BP1 blocks cGAS condensation and suppresses interferon response to cytoplasmic DNA.\",\n      \"method\": \"Co-immunoprecipitation, knockdown, immunofluorescence, interferon response assays\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP with functional knockdown, single lab\",\n      \"pmids\": [\"31772125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Structured expansion RNAs (CAG, CCUG, CAGG, G4C2) activate PKR, which promotes RAN (repeat-associated non-AUG) translation; blocking PKR with dominant-negative PKR-K296R or PKR-KO reduces RAN protein levels; metformin inhibits PKR and reduces RAN proteins and improves pathology in C9orf72 ALS/FTD mice.\",\n      \"method\": \"PKR-KO cells, dominant-negative PKR, AAV-mediated PKR inhibition in transgenic mice, RAN protein quantification\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with in vivo mouse model and multiple orthogonal approaches\",\n      \"pmids\": [\"32690681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PKR activation in colonic epithelial cells promotes eIF2α-mediated UPR signaling, STAT3, and AKT activation to protect against DSS-induced colitis; PKR-/- mice show impaired UPR, reduced STAT3/AKT phosphorylation, and more severe colitis.\",\n      \"method\": \"PKR knockout mice, bone marrow reconstitution, western blot, histology\",\n      \"journal\": \"Inflammatory bowel diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean knockout with defined molecular phenotypes, single lab\",\n      \"pmids\": [\"22275310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PKR kinase activity represses cryopyrin (NLRP3) inflammasome activity by inhibiting protein translation of inflammasome constituents to prevent initial priming; kinase-dead knock-in and PKR-null mice showed enhanced inflammasome activity, contradicting earlier findings that PKR promotes inflammasome activation.\",\n      \"method\": \"Knock-in mouse with kinase-dead PKR point mutation, PKR-null mouse, inflammasome activity assays\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — dual transgenic mouse genetics (kinase-dead knock-in vs. full KO) dissecting kinase-dependent function\",\n      \"pmids\": [\"26794869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Stress-induced phosphorylation of TRBP enhances its interaction with PKR and inhibits PKR activity more efficiently, promoting cell survival by preventing sustained PKR-mediated apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, TRBP phospho-mutants, PKR activity assays, cell survival assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP with functional follow-up, single lab\",\n      \"pmids\": [\"29348664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PKR activation during ER stress (via PACT) promotes p53 sumoylation on Lys386 through interaction with SUMO E2 ligase Ubc9; this pathway requires both PACT and PKR and leads to p53 stability, p21 induction, and G1 cell cycle arrest.\",\n      \"method\": \"Co-expression, dominant-negative PKR, PKR-null MEFs, sumoylation assays, cell cycle analysis\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — genetic epistasis with PKR-null MEFs and sumoylation-deficient p53 mutant, single lab\",\n      \"pmids\": [\"22214662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CircRNA-CREIT acts as a scaffold to facilitate interaction between PKR and E3 ubiquitin ligase HACE1, promoting K48-linked polyubiquitylation and proteasomal degradation of PKR protein, thereby reducing PKR/eIF2α signaling and stress granule assembly.\",\n      \"method\": \"RNA pull-down, Co-IP, ubiquitylation assays, western blot, animal models\",\n      \"journal\": \"Journal of hematology & oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP with ubiquitylation assay showing PTM mechanism, single lab\",\n      \"pmids\": [\"36038948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CircWDR37 binds to and dimerizes PKR to initiate PKR autophosphorylation; phosphorylated PKR induces IKKβ phosphorylation and releases RELA from IκBα (independent of PKR kinase activity for NF-κB activation) to stimulate NF-κB target gene transcription driving senescence.\",\n      \"method\": \"RNA pull-down, Co-IP, PKR dimerization assays, IKKβ phosphorylation, NF-κB reporter, kinase-dead mutant\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — multiple pulldown and phosphorylation assays with mechanistic dissection, single lab\",\n      \"pmids\": [\"36683218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"APOBEC3B forms a complex with PABPC1 to stimulate PKR and counterbalance the PKR-suppressing activity of ADAR1 during viral infection; APOBEC3B localizes to stress granules through interaction with PABPC1 and protects mRNA in stress granules from RNase L-mediated cleavage.\",\n      \"method\": \"Co-immunoprecipitation, PKR phosphorylation assays, stress granule imaging, RNase L assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP with functional follow-up, single lab\",\n      \"pmids\": [\"36781883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"EIF2AK2/PKR is a direct binding target of berberine; berberine inhibits PKR dimerization (rather than its enzymatic activity), selectively modulating downstream JNK, NF-κB, AKT, and NLRP3 pathways; EIF2AK2 knockdown attenuates berberine's anti-inflammatory effects.\",\n      \"method\": \"Chemoproteomics (thermal shift, DARTS), isothermal titration calorimetry, PKR dimerization assay, EIF2AK2 knockdown mice\",\n      \"journal\": \"Acta pharmaceutica Sinica. B\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct target ID by chemoproteomic methods with in vivo knockdown validation, single lab\",\n      \"pmids\": [\"37250154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Heterozygous de novo missense variants in EIF2AK2 cause reduced kinase activity in patient-derived fibroblasts and mammalian cell lines, resulting in impaired eIF2α phosphorylation; this establishes EIF2AK2 kinase activity as required for normal neurodevelopment.\",\n      \"method\": \"Patient-derived fibroblasts, heterologous kinase activity assays\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional kinase assay in patient-derived cells, multiple probands\",\n      \"pmids\": [\"32197074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Reduction of renal tubular PNPT1 causes leakage of mitochondrial dsRNA into the cytoplasm, activating PKR and leading to eIF2α phosphorylation and translational arrest; PKR inhibition rescues renal tubular injury in ischemia-reperfusion and ureteral obstruction mouse models.\",\n      \"method\": \"PKR inhibition (pharmacological and genetic), PNPT1 knockout mice, eIF2α phosphorylation assays, mouse injury models\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological PKR inhibition in vivo with clear pathway placement (PNPT1→mtdsRNA→PKR→eIF2α)\",\n      \"pmids\": [\"36869030\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"EIF2AK2/PKR is an interferon-induced serine/threonine kinase that is activated by dsRNA binding to its N-terminal dsRBD, which relieves autoinhibitory intramolecular interactions and promotes kinase domain dimerization via a conserved salt bridge interface, triggering cis-autophosphorylation on Thr446 and enabling specific recognition and phosphorylation of eIF2α on Ser51 to inhibit global translation; PKR can also be activated by the cellular protein PACT (upon stress-induced phosphorylation), endogenous dsRNAs (mitochondrial RNAs, inverted Alu repeats during mitosis, circRNAs), and heparin, and is negatively regulated by STAT3, TRBP, ADAR1, Hsp90/p23, and circRNA duplexes; beyond translational control, PKR activates NF-κB both kinase-dependently (through phosphorylation) and kinase-independently (by physically interacting with IKKβ and TRAF2/5), promotes inflammasome assembly by interacting with NLRP3/NLRC4/AIM2/ASC, initiates RIP1/RIP3-dependent necroptosis by binding RIP1, and regulates autophagy, mitosis, and apoptosis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"EIF2AK2 (PKR) is an interferon-induced serine/threonine kinase that serves as a central cytoplasmic sensor of double-stranded RNA, integrating pathogen detection, endogenous RNA surveillance, and cellular stress into translational control, innate immune signaling, and cell fate decisions. Activation occurs when dsRNA (≥30 bp) or the stress-responsive protein PACT binds the N-terminal dsRNA-binding domain, relieving an autoinhibitory intramolecular interaction between the dsRBD and kinase domain, thereby promoting kinase-domain dimerization through a conserved Arg262–Asp266 salt bridge and cis-autophosphorylation of Thr446 in the activation loop, which enables specific phosphorylation of eIF2α on Ser51 to suppress global translation [PMID:16179259, PMID:16785445, PMID:18599071, PMID:17202131, PMID:24338483]. PKR is negatively regulated by ADAR1p150 (via direct dsRBD3–kinase domain contact on dsRNA), STAT3 (SH2-domain interaction with the catalytic domain), TRBP, Hsp90/p23, and endogenous circRNA duplexes, while endogenous activating ligands include mitochondrial dsRNAs, inverted Alu repeat transcripts released during mitosis, snoRNAs, and structured repeat expansion RNAs [PMID:39146181, PMID:23084476, PMID:11447118, PMID:31031002, PMID:30174290, PMID:24939934, PMID:25848059, PMID:32690681]. Beyond translational control, PKR activates NF-κB both kinase-dependently and kinase-independently through physical interactions with IKKβ and TRAF2/5, promotes inflammasome assembly by interacting with NLRP3/NLRC4/AIM2/ASC, initiates RIP1/RIP3-dependent necroptosis, and forms dsRNA-induced cytoplasmic condensates (dRIFs) that buffer downstream integrated stress response signaling [PMID:10848580, PMID:15121867, PMID:22801494, PMID:23898178, PMID:35939694, PMID:35522180].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing that PKR is a dsRNA-activated kinase that phosphorylates eIF2α to inhibit translation and activates NF-κB-dependent inflammatory gene transcription provided the foundational dual-function framework for all subsequent mechanistic dissection.\",\n      \"evidence\": \"Biochemical assays, in vitro kinase assays, and cell-based studies\",\n      \"pmids\": [\"10557102\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of NF-κB activation not resolved\", \"No structural basis for dsRNA-dependent activation\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrating that PKR activates NF-κB independently of its kinase activity through physical interaction with IKKβ revealed a scaffolding function distinct from its catalytic role.\",\n      \"evidence\": \"GST pull-down with kinase-dead PKR mutant, NF-κB reporter assay in PKR-null cells\",\n      \"pmids\": [\"10848580\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether kinase-dependent and kinase-independent NF-κB pathways operate simultaneously in vivo\", \"Stoichiometry of PKR-IKKβ interaction unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identifying Hsp90/p23 as a chaperone complex that binds PKR and holds it in a latent state — with dsRNA or Hsp90 inhibitors triggering dissociation and activation — established a negative regulatory mechanism independent of dsRNA-binding competitors.\",\n      \"evidence\": \"Co-immunoprecipitation, geldanamycin treatment, yeast Hsp90 mutant system\",\n      \"pmids\": [\"11447118\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Hsp90 regulates PKR stability vs. conformation in vivo\", \"Structural basis of Hsp90-PKR interaction unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Mapping PKR's physical interaction with TRAF2 and TRAF5 via a TRAF-interaction motif in the kinase domain, and showing this is required for NF-κB activation, placed PKR within canonical TNF receptor signaling adaptor networks.\",\n      \"evidence\": \"Co-immunoprecipitation, TRAF-deficient cell lines, dominant-negative expression\",\n      \"pmids\": [\"15121867\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TRAF and IKKβ interactions are sequential or alternative\", \"Direct ubiquitylation events downstream of PKR-TRAF not characterized\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Resolving that PKR activation requires catalytic-domain dimerization that triggers Thr446 autophosphorylation, and that helix αG mediates specific eIF2α substrate recognition, provided the structural logic for how dsRNA binding translates into kinase activity.\",\n      \"evidence\": \"Mutagenesis, in vitro kinase assays, yeast growth suppression, pseudosubstrate binding\",\n      \"pmids\": [\"16179259\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length PKR crystal structure with dsRNA not available\", \"Kinetics of dimerization vs. autophosphorylation not quantified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Two complementary studies established that PKR activation involves both relief of an autoinhibitory intramolecular dsRBD–kinase domain interaction and dsRNA-induced dimerization, showing these are two facets of the same activation mechanism requiring ≥30 bp dsRNA to bridge two PKR monomers.\",\n      \"evidence\": \"NMR, sedimentation velocity AUC, point mutagenesis, in vitro kinase assays with defined-length dsRNAs\",\n      \"pmids\": [\"16785445\", \"17196820\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether autoinhibition release and dimerization are obligatorily coupled or separable\", \"Dynamics of dsRNA scanning not resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identifying the conserved Arg262–Asp266 salt bridge at the PKR dimer interface as essential for all eIF2α kinase family members — with charge-swap rescue confirming the contact — generalized the dimerization mechanism across the family.\",\n      \"evidence\": \"Charge-swap mutagenesis, yeast functional assay, in vitro kinase assay\",\n      \"pmids\": [\"17202131\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other eIF2α kinases use identical interface geometry\", \"Allosteric communication from dimer interface to active site not mapped\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Showing that positively selected residues near PKR's eIF2α binding site confer species-specific sensitivity to poxviral pseudosubstrate inhibitors revealed the evolutionary arms race driving PKR diversification while maintaining substrate specificity.\",\n      \"evidence\": \"Evolutionary analysis, site-directed mutagenesis, in vitro kinase assays with poxviral inhibitors\",\n      \"pmids\": [\"19043413\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether host-virus co-evolution at this interface drives compensatory eIF2α changes\", \"Structural basis of pseudosubstrate vs. true substrate discrimination\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrating that PACT-mediated PKR activation during ER stress requires stress-induced PACT phosphorylation and direct PACT–PKR interaction, with PACT-null and PKR-null cells resistant to ER stress-induced apoptosis, established PACT as a physiological dsRNA-independent PKR activator coupling ER stress to cell death.\",\n      \"evidence\": \"PACT/PKR null cell lines, cDNA reconstitution, in vitro interaction assays, apoptosis assays, phosphomimetic mutagenesis\",\n      \"pmids\": [\"19007793\", \"19580324\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the kinase(s) that phosphorylate PACT domain 3 serines under ER stress\", \"Whether PACT also induces PKR dimerization or uses a distinct activation mode\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstrating that PKR distinguishes uridine- from pseudouridine-containing mRNA — with pseudouridine preventing PKR binding and activation — revealed a chemical basis for innate immune discrimination of self vs. non-self RNA that later informed mRNA therapeutic design.\",\n      \"evidence\": \"RNA pull-down, in vitro kinase assay, PKR knockout cell validation\",\n      \"pmids\": [\"20457754\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other base modifications similarly modulate PKR recognition\", \"In vivo stoichiometry of PKR-mRNA encounters not quantified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showing that heparin activates PKR by binding the kinase domain (not dsRBD) and allosterically enhancing dimerization identified a structurally distinct, non-RNA activation mode and expanded the repertoire of PKR ligands.\",\n      \"evidence\": \"Analytical ultracentrifugation, in vitro autophosphorylation, thermodynamic linkage analysis\",\n      \"pmids\": [\"21978664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of heparin-PKR interaction in vivo unclear\", \"Structural details of heparin binding site not resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Three studies in 2012 expanded PKR's cellular roles beyond translation: PKR was shown to physically interact with multiple inflammasome sensors (NLRP3, AIM2, NLRC4, ASC) and be required for inflammasome assembly; STAT3 was identified as a direct inhibitor of PKR autophosphorylation; and PKR was linked to p53 sumoylation and cell cycle arrest during ER stress.\",\n      \"evidence\": \"Cell-free inflammasome reconstitution with PKR KO; recombinant STAT3 pull-down with domain mutants; PKR-null MEFs with sumoylation assays\",\n      \"pmids\": [\"22801494\", \"23084476\", \"22214662\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The 2016 kinase-dead knock-in study contradicted PKR as a positive inflammasome regulator, creating unresolved controversy\", \"Direct phosphorylation targets linking PKR to inflammasome assembly not identified\", \"Whether STAT3 inhibition of PKR operates in all cell types\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Two findings in 2013 refined the activation mechanism and expanded downstream effectors: dimerization-induced cis-phosphorylation of Thr446 was shown to be the obligate activation step, and PKR was found to interact with RIP1 to initiate necroptosis when caspases are inactive.\",\n      \"evidence\": \"Engineered bypass mutants in yeast with in vitro kinase assays; Co-IP with PKR-deficient cells and kinase-dead mutants\",\n      \"pmids\": [\"24338483\", \"23898178\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PKR directly phosphorylates RIP1 or acts as a scaffold for necrosome formation\", \"Structural basis for cis- vs. trans-autophosphorylation not fully resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Discovery that PKR is activated during normal mitosis by inverted Alu repeat dsRNAs released upon nuclear envelope breakdown — suppressing translation and regulating mitotic progression — established a physiological, non-pathogen-related function for PKR in cell division.\",\n      \"evidence\": \"RNAi knockdown, dominant-negative mutant, dsRNA immunoprecipitation, live-cell imaging, flow cytometry\",\n      \"pmids\": [\"24939934\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How mitotic PKR activation is terminated after cytokinesis\", \"Whether other endogenous dsRNA sensors also respond to IRAlus during mitosis\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of DHX36 as an ATPase/helicase that forms a dsRNA-dependent complex with PKR and facilitates its phosphorylation connected PKR activation to RNA helicase-mediated dsRNA processing and stress granule/RIG-I signaling.\",\n      \"evidence\": \"Co-immunoprecipitation, DHX36 knockout inducible MEFs, PKR phosphorylation assays\",\n      \"pmids\": [\"24651521\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether DHX36 remodels dsRNA structure to enhance PKR binding or stabilizes the PKR-dsRNA complex\", \"Generalizability to other DEAH-box helicases\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identifying snoRNAs as PKR-binding activators after metabolic stress broadened the endogenous RNA activator repertoire beyond canonical dsRNA and Alu repeats.\",\n      \"evidence\": \"RIP-Seq, UV crosslinking IP, in vitro PKR activation assay, snoRNA transfection\",\n      \"pmids\": [\"25848059\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which snoRNA structural features are sufficient for PKR activation\", \"Whether snoRNA-PKR interaction occurs under non-metabolic stress conditions\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Using kinase-dead knock-in and PKR-null mice, a contradictory finding showed that PKR kinase activity represses NLRP3 inflammasome priming by inhibiting translation of inflammasome constituents, directly opposing the 2012 report of PKR as a positive inflammasome activator.\",\n      \"evidence\": \"Kinase-dead PKR knock-in mouse, PKR-null mouse, inflammasome activity assays\",\n      \"pmids\": [\"26794869\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Reconciliation of opposing inflammasome findings remains unresolved — may reflect cell type, stimulus, or kinetics differences\", \"Whether scaffolding vs. kinase functions of PKR have opposing effects on inflammasome\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Three 2018 studies expanded the network of endogenous PKR regulators: mitochondrial dsRNAs formed by bidirectional transcription were identified as constitutive PKR ligands held in check by phosphatases; stress-induced TRBP phosphorylation was shown to enhance its PKR-inhibitory function; and PACT was placed genetically upstream of PKR in stress granule formation via TIA1/TIAL1 epistasis.\",\n      \"evidence\": \"fCLIP-seq with functional validation; TRBP phospho-mutant Co-IP; PAR-CLIP with double KO and genetic rescue\",\n      \"pmids\": [\"30174290\", \"29348664\", \"29429924\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the phosphatases that counteract mtdsRNA-induced PKR activation\", \"Whether TRBP and PACT compete for the same PKR binding site\", \"Quantitative contribution of mtdsRNA vs. nuclear dsRNA to basal PKR activity\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Endogenous circRNAs were identified as tonic PKR inhibitors through short imperfect dsRNA duplexes, with RNase L-mediated circRNA degradation during viral infection required for PKR derepression — linking circRNA metabolism to innate immune activation and providing a mechanism relevant to SLE autoimmunity.\",\n      \"evidence\": \"Cellular overexpression/knockdown, RNase L degradation assays, PKR phosphorylation analysis in patient PBMCs\",\n      \"pmids\": [\"31031002\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which specific circRNAs are the dominant PKR suppressors in different tissues\", \"Whether circRNA-PKR inhibition is stoichiometric or catalytic\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Two findings extended PKR's disease relevance: structured repeat expansion RNAs were shown to activate PKR and promote pathological RAN translation in ALS/FTD models, while de novo EIF2AK2 missense variants causing reduced kinase activity were linked to a neurodevelopmental disorder, establishing PKR as essential for normal brain development.\",\n      \"evidence\": \"PKR-KO cells and dominant-negative PKR with AAV-mediated inhibition in C9orf72 mice; patient-derived fibroblast kinase assays across multiple probands\",\n      \"pmids\": [\"32690681\", \"32197074\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PKR-driven RAN translation is eIF2α-dependent or uses an alternative mechanism\", \"Full phenotypic spectrum of EIF2AK2 loss-of-function in humans not defined\", \"Whether neurodevelopmental pathology reflects translational control, NF-κB, or other PKR effector arm\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Live-cell imaging revealed that PKR forms dynamic cytoplasmic condensates (dRIFs/clusters) upon dsRNA stimulation that buffer eIF2α phosphorylation — with eIF2α excluded from clusters and cluster disruption enhancing ISR signaling — introducing a phase-separation/clustering layer to PKR regulation.\",\n      \"evidence\": \"Live-cell imaging, mutagenesis, eIF2α phosphorylation assays, dsRNA stimulation\",\n      \"pmids\": [\"35939694\", \"35522180\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Material properties (liquid vs. gel) of dRIFs not characterized\", \"Whether dRIF formation occurs at physiological PKR concentrations in primary cells\", \"Relationship between dRIFs and canonical stress granules not fully resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"In vivo epistasis in triple-knockout mice demonstrated that ADAR1p150 prevents PKR activation via dsRNA binding (editing-independent), while ADAR1 editing prevents MDA5 activation — with combined MDA5/PKR deletion fully rescuing Adar1p150 embryonic lethality — definitively separating ADAR1's editing and PKR-inhibitory functions.\",\n      \"evidence\": \"Triple knockout mouse genetics, epistasis analysis\",\n      \"pmids\": [\"37797622\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether ADAR1p150 sequesters dsRNA from PKR or directly contacts PKR on dsRNA\", \"Tissue-specific contributions of ADAR1-PKR vs. ADAR1-MDA5 axes\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Mapping the direct ADAR1 dsRBD3–PKR kinase domain contact surface on dsRNA — with mutagenesis abolishing interaction, co-localization, and PKR inhibition while editing-inactive ADAR1 retained inhibitory activity — resolved that ADAR1 inhibits PKR through a direct protein-protein interaction on dsRNA rather than by editing away dsRNA substrates.\",\n      \"evidence\": \"AlphaFold structural modeling, mutagenesis, Co-IP, in vivo/in vitro PKR phosphorylation assays\",\n      \"pmids\": [\"39146181\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystal structure of the ternary ADAR1-dsRNA-PKR complex not yet determined\", \"Whether this contact surface is targetable for therapeutic modulation of PKR in autoimmune disease\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis of full-length PKR bound to dsRNA; whether PKR's opposing roles in inflammasome regulation reflect cell-type or stimulus-specific contexts; the mechanism by which PKR condensates buffer ISR signaling; and whether PKR's scaffolding vs. kinase functions can be selectively targeted therapeutically.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No full-length PKR-dsRNA co-crystal structure\", \"Inflammasome promotion vs. repression controversy unresolved\", \"Phase separation mechanism and physiological relevance of dRIFs need reconstitution\", \"Selective targeting of scaffolding vs. kinase activity not demonstrated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 5, 6, 17, 23]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [3, 4, 12, 13, 14, 15, 20]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [7, 8, 10, 11, 29]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [7, 8, 28]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 14, 24, 25]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [24]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 7, 8, 10, 11, 12, 26, 27]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 6, 13, 14, 15, 29]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [11, 18]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [12, 15, 20]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [7, 8, 9, 28, 35]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [9, 16, 18, 24]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"EIF2S1\",\n      \"PRKRA\",\n      \"ADAR\",\n      \"TRAF2\",\n      \"IKBKB\",\n      \"DHX36\",\n      \"RIPK1\",\n      \"NLRP3\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}